10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)
x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2017
OR
¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM             TO

Commission file number: 001-37401

Community Healthcare Trust Incorporated

(Exact Name of Registrant as Specified in Its Charter)

Maryland (State or Other Jurisdiction of Incorporation or Organization) 46-5212033 (I.R.S. Employer Identification No.)

3326 Aspen Grove Drive

Suite 150

Franklin, Tennessee 37067

(Address of Principal Executive Offices) (Zip Code)

(615) 771-3052

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x     No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x     No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated  filer ¨ Accelerated filer x Emerging-growth company x Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting  company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section13(a) of the Exchange Act. x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes  ¨     No x

The Registrant had 18,085,798 shares of Common Stock, $0.01 par value per share, outstanding as of October 31, 2017.

1

COMMUNITY HEALTHCARE TRUST INCORPORATED

FORM 10-Q

September 30, 2017

TABLE OF CONTENTS

		Page
PART I.—FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statement of Stockholders' Equity	6
	Condensed Consolidated Statements of Cash Flows	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	37
Item 4.	Controls and Procedures	37
PART II.—OTHER INFORMATION		37
Item 1.	Legal Proceedings	37
Item 1A.	Risk Factors	37
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38
Item 3.	Defaults Upon Senior Securities	38
Item 4.	Mine Safety Disclosures	38
Item 5.	Other Information	38
Item 6.	Exhibits	38
SIGNATURES		40

2

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share amounts)

	(Unaudited)
	September 30, 2017			December 31, 2016
ASSETS
Real estate properties
Land and land improvements	$	39,810		$	29,884
Buildings, improvements, and lease intangibles	307,492			222,755
Personal property	112			97
Total real estate properties	347,414			252,736
Less accumulated depreciation	(31,153		)	(18,404		)
Total real estate properties, net	316,261			234,332
Cash and cash equivalents	17,479			1,568
Mortgage note receivable, net	10,633			10,786
Other assets, net	10,776			4,843
Total assets	$	355,149		$	251,529
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Debt, net	$	59,284		$	51,000
Accounts payable and accrued liabilities	3,226			3,541
Other liabilities	4,743			2,981
Total liabilities	67,253			57,522
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	—			—
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,085,798 and 12,988,482 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	181			130
Additional paid-in capital	323,877			214,323
Cumulative net income	3,223			1,265
Accumulated other comprehensive loss	(386		)	—
Cumulative dividends	(38,999		)	(21,711		)
Total stockholders’ equity	287,896			194,007
Total liabilities and stockholders' equity	$	355,149		$	251,529

See accompanying notes to the condensed consolidated financial statements.

3

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016

(Unaudited; Dollars in thousands, except per share amounts)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
REVENUES
Rental income	$	8,012		$	4,985		$	21,968		$	13,188
Tenant reimbursements	1,158			1,188			3,620			3,250
Mortgage interest	255			270			774			1,367
Other operating	19			—			19			—
	9,444			6,443			26,381			17,805
EXPENSES
Property operating	2,225			963			6,103			3,240
General and administrative	1,069			671			2,674			2,372
Depreciation and amortization	4,544			3,496			12,749			9,643
Bad debts	—			73			67			103
	7,838			5,203			21,593			15,358
OTHER INCOME (EXPENSE)
Interest expense	(1,091		)	(185		)	(2,897		)	(787		)
Interest and other income, net	64			9			67			28
	(1,027		)	(176		)	(2,830		)	(759		)
NET INCOME	$	579		$	1,064		$	1,958		$	1,688
NET INCOME PER COMMON SHARE:
Net income per common share – Basic	$	0.02		$	0.08		$	0.10		$	0.16
Net income per common share – Diluted	$	0.02		$	0.08		$	0.10		$	0.16
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC	16,241,986			12,686,183			13,884,476			10,752,333
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED	16,241,986			12,750,967			13,884,476			10,802,095
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD	$	0.3925		$	0.3825		$	1.1700		$	1.1400

See accompanying notes to the condensed consolidated financial statements.

4

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2017 AND 2016

(Unaudited; Dollars in thousands)

			Three Months Ended September 30,					Nine Months Ended  September 30,
			2017			2016		2017			2016
NET INCOME			$	579		$	1,064	$	1,958		$	1,688
	Other comprehensive income (loss):
		Unrealized losses on cash flow hedges	(74		)	—		(672		)	—
		Reclassification of loss amounts recognized as interest expense	124			—		286			—
	Total other comprehensive income (loss)		50			—		(386		)	—
COMPREHENSIVE INCOME			$	629		$	1,064	$	1,572		$	1,688

See accompanying notes to the condensed consolidated financial statements.

5

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

(Unaudited; Dollars in thousands, except per share amounts)

	Preferred Stock		Common Stock		Additional Paid in Capital		Cumulative Net Income		Accumulated Other Comprehensive Loss			Cumulative Dividends			Total Stockholders' Equity
Balance at December 31, 2016	$	—	$	130	$	214,323	$	1,265	$	—		$	(21,711	)	$	194,007
Issuance of common stock, net of issuance costs	—		49		108,506		—		—			—			108,555
Stock-based compensation	—		2		1,048		—		—			—			1,050
Unrecognized loss on cash flow hedges	—		—		—		—		(672		)	—			(672		)
Reclassification adjustment for losses included in net income (interest expense)	—		—		—		—		286			—			286
Net income	—		—		—		1,958		—			—			1,958
Dividends to common stockholders ($1.17 per share)	—		—		—		—		—			(17,288		)	(17,288		)
Balance at September 30, 2017	$	—	$	181	$	323,877	$	3,223	$	(386	)	$	(38,999	)	$	287,896

See accompanying notes to the condensed consolidated financial statements.

6

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; Dollars in thousands)

	Nine Months Ended September 30,
	2017			2016
OPERATING ACTIVITIES
Net income	$	1,958		$	1,688
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	13,053			9,749
Stock-based compensation	1,050			453
Straight-line rent receivable	(980		)	(405		)
Straight-line rent liability	27			—
Provision for bad debts, net of recoveries	67			103
Reduction in contingent purchase price	(5		)	(974		)
Changes in operating assets and liabilities:
Other assets	(636		)	(1,284		)
Accounts payable and accrued liabilities	(404		)	1,732
Other liabilities	1,234			(262		)
Net cash provided by operating activities	15,364			10,800
INVESTING ACTIVITIES
Acquisitions of real estate	(93,442		)	(58,249		)
Funding of notes receivable	(5,000		)	(12,406		)
Proceeds from the repayment of notes receivable	296			—
Capital expenditures on existing real estate properties	(545		)	(1,123		)
Net cash used in investing activities	(98,691		)	(71,778		)
FINANCING ACTIVITIES
Net repayments on revolving credit facility	(51,000		)	(12,000		)
Term loan borrowings	60,000			—
Dividends paid	(17,288		)	(12,782		)
Net proceeds from issuance of common stock	109,168			86,805
Equity issuance costs	(465		)	(680		)
Debt issuance costs	(784		)	(641		)
Settlement of contingent purchase price	(393		)	—
Net cash provided by financing activities	99,238			60,702
Increase (decrease) in cash and cash equivalents	15,911			(276		)
Cash and cash equivalents, beginning of period	1,568			2,018
Cash and cash equivalents, end of period	$	17,479		$	1,742
Supplemental Cash Flow Information:
Interest paid	$	2,390		$	504
Invoices accrued for construction, tenant improvement and other capitalized costs	$	3		$	145
Reclassification between accounts and notes receivable	$	615		$	—
Reclassification of registration statement costs incurred in prior year to equity issuance costs	$	148		$	—
Conversion of mortgage note upon acquisition of real estate property	$	—		$	12,500
Decrease in fair value of cash flow hedges	$	(672	)	$	—

See accompanying notes to the condensed consolidated financial statements.

7

COMMUNITY HEALTHCARE TRUST INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2017

(Unaudited)

Note 1. Summary of Significant Accounting Policies

Business Overview

Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by its operating partnership (the "OP"), either directly or through subsidiaries. The Company is the sole general partner of the OP, owning 100% of the OP units. As of September 30, 2017, the Company had investments of approximately $358.0 million in 80 real estate properties, including a mortgage note, located in 26 states, totaling approximately 1.8 million square feet in the aggregate.

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2017.

Principles of Consolidation

Our Condensed Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, and may also include joint ventures, partnerships and variable interest entities, or VIEs, where the Company controls the operating activities. All material intercompany accounts and transactions have been eliminated.

Management must make judgments regarding the Company's level of influence or control over an entity and whether or not the Company is the primary beneficiary of a VIE. Consideration of various factors include, but is not limited to, the Company's ability to direct the activities that most significantly impact the entity's governing body, the size and seniority of the Company's investment, and the Company's ability to replace the manager and/or liquidate the entity. Management's ability to correctly assess its influence or control over an entity when determining the primary beneficiary of a VIE affects the presentation of these entities in the Company's Condensed Consolidated Financial Statements. If it is determined that the Company is the primary beneficiary of a VIE, the Company's Condensed Consolidated Financial Statements would include the operating results of the VIE rather than the results of the variable interest in the VIE. Untimely or inaccurate financial information provided to the Company or deficiencies in the VIEs internal control over financial reporting could impact the Company's Condensed Consolidated Financial Statements and its own internal control over financial reporting.

During the third quarter of 2017, concurrent with the acquisition of a property, the Company entered into a $5.0 million note receivable with the tenant in the building. See Note 4. The Company identified the borrower as a VIE, but management determined that the Company was not the primary beneficiary of the VIE because we lack either directly or through related parties any material impact in the activities that impact its economic performance.

8

Notes to Condensed Consolidated Financial Statements - Continued

We are not obligated to provide support beyond our stated commitment to the borrower, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding note receivable as noted above.

Jumpstart Our Business Startups Act of 2012

The Company has elected the "emerging growth company" status as permitted under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The Company elected to "opt out" of the provision allowed under the JOBS Act to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. As a result, we must comply with new or revised accounting standards as required when they are adopted. Our decision to opt out of the extended transition period under the JOBS Act is irrevocable.

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Segment Reporting

The Company acquires and owns healthcare-related real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single segment.

Cash and Cash Equivalents

Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased.

Accounting for Real Estate Property Acquisitions

Real estate property acquisitions are accounted for as a business combination or an asset acquisition. An acquisition accounted for as a business combination is recorded at fair value and related closing costs are expensed. An acquisition accounted for as an asset acquisition is recorded at its purchase price, inclusive of acquisition costs, which is allocated among the acquired assets and assumed liabilities based upon their relative fair values at the date of acquisition. The Company adopted Accounting Standards Update ("ASU") No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, on January 1, 2017, and Company expects that substantially all of its acquisitions will be accounted for as asset acquisitions.

The allocation of real estate property acquisitions may include land and land improvements, building and building improvements, personal property, and identified intangible assets and liabilities (consisting of above- and below-market leases, in-place leases, and tenant relationships) based on the evaluation of information and estimates available at that date, and we allocate the purchase price based on these assessments. We make estimates of the acquisition date fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence, tax records, and other sources. Based on these estimates, we recognize the acquired assets and liabilities at their estimated fair values. We expense transaction costs associated with business combinations in the period incurred. The fair value of tangible property assets acquired considers the value of the property as if vacant determined by comparable sales and other relevant data. The determination of fair value involves the use of significant judgment and estimation. We value land based on various inputs, which may include internal analysis of recently acquired properties, existing comparable properties within our portfolio, or third party appraisals or valuations based on comparable sales.

In recognizing identified intangible assets and liabilities of an acquired property, the value of above- or below-market leases is estimated based on the present value (using a discount rate which reflects the risks associated with the leases acquired) of the difference between contractual amounts to be received pursuant to the leases and management’s estimate of market lease rates measured over a period equal to the estimated remaining term of the

9

Notes to Condensed Consolidated Financial Statements - Continued

lease. In the case of a below-market lease, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The capitalized above-market or below-market lease intangibles are amortized as a reduction from or an addition to rental income over the estimated remaining term of the respective leases.

In determining the value of in-place leases and tenant relationships, management considers current market conditions and costs to execute similar leases in arriving at an estimate of the carrying costs during the expected lease-up period from vacant to existing occupancy. In estimating carrying costs, management includes real estate taxes, insurance, other property operating expenses, estimates of lost rental revenue during the expected lease-up periods, and costs to execute similar leases, including leasing commissions. The values assigned to in-place leases and tenant relationships are amortized over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.

Depreciation and amortization of real estate assets and liabilities in place as of September 30, 2017, is recognized on a straight-line basis over the estimated useful life of the asset. The estimated useful lives at September 30, 2017 are as follows:

Land improvements	3 - 15 years
Buildings	20 - 40 years
Building improvements	3.0 - 39.8 years
Tenant improvements	2.3 - 6.9 years
Lease intangibles	1.4 - 13.7 years
Personal property	3 -10 years

Asset Impairments

The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant under-performance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its operators. In addition, the Company’s review for possible impairment may include those assets subject to purchase options and those impacted by casualties, such as tornadoes and hurricanes. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property.

Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements.

A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

• Level 1 – quoted prices for identical instruments in active markets;

• Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

10

Notes to Condensed Consolidated Financial Statements - Continued

• Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Our interest rate swaps are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as Level 2 in the hierarchy.

Lease Accounting

We, as a lessor, make a determination with respect to each of our leases whether they should be accounted for as operating leases or capital leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic useful life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. We believe all of our leases meet the accounting criteria to be accounted for as operating leases. Payments received under operating leases are accounted for in the Condensed Consolidated Statements of Income as rental revenue for actual cash rent collected plus or minus straight-line adjustments resulting from lease escalators. Assets subject to operating leases are reported as real estate investments in the Condensed Consolidated Balance Sheets.

Substantially all of our leases contain fixed or formula-based rent escalators. To the extent that the escalators are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

Revenue Recognition

The Company recognizes rental revenue when it is realized or realizable and earned. There are four criteria that must be met before a company may recognize revenue, including persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered (i.e., the tenant has taken possession of and controls the physical use of the leased asset), the price has been fixed or is determinable, and collectability is reasonably assured.

The Company derives most of its revenues from its real estate and mortgage note portfolio. The Company's rental and interest income is recognized based on contractual arrangements with its tenants and borrowers.

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue in amounts more or less than amounts currently due from tenants. If management determines that the collectability of straight-line rents is not reasonably assured, the amount of future revenue recognized may be limited to amounts contractually owed and, where appropriate, establish an allowance for estimated losses. Straight-line rent included in rental income was approximately $0.4 million and $0.2 million, respectively, for the three months ended September 30, 2017 and 2016 and $1.0 million and $0.4 million, respectively, for the nine months ended September 30, 2017 and 2016.

Interest income is recognized based on the interest rates, maturity dates and amortization periods set forth within each note agreement. Fees received related to our mortgage note are amortized to mortgage interest income on a straight-line basis which approximates amortization under the effective interest method.

Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities, was approximately $0.9 million and $0.8 million, respectively, at September 30, 2017 and December 31, 2016.

Allowance for Doubtful Accounts and Credit Losses

Accounts Receivable

Management monitors the aging and collectability of its accounts receivable balances on an ongoing basis. Whenever deterioration in the timeliness of payment from a tenant is noted, management investigates and determines the reason or reasons for the delay. Considering all information gathered, management’s judgment is exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage

11

Notes to Condensed Consolidated Financial Statements - Continued

may be uncollectible. Among the factors management considers in determining collectability are: the type of contractual arrangement under which the receivable was recorded (e.g., triple net lease, gross lease, or other type of agreement); the tenant’s reason for slow payment; industry influences under which the tenant operates; evidence of willingness and ability of the tenant to pay the receivable; credit-worthiness of the tenant; collateral, security deposit, letters of credit or other monies held as security; tenant’s historical payment pattern; other contractual agreements between the tenant and the Company; relationship between the tenant and the Company; the state in which the tenant operates; and the existence of a guarantor and the willingness and ability of the guarantor to pay the receivable. Considering these factors and others, management concludes whether all or some of the aged receivable balance is likely uncollectible. Upon determining that some portion of the receivable is likely uncollectible, the Company will record a provision for bad debts for the amount it expects will be uncollectible. When efforts to collect a receivable are exhausted, the receivable amount is charged off against the allowance. At September 30, 2017 and December 31, 2016, the Company had an allowance for bad debts of approximately $293,000 and $154,000, respectively.

Mortgage Note and Notes Receivable

The Company evaluates collectability of its notes receivable and records allowances as necessary. A note is impaired when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan as scheduled, including both contractual interest and principal payments. This assessment also includes an evaluation of the loan collateral. If a mortgage loan becomes past due, the Company will review the specific circumstances and may discontinue the accrual of interest on the loan. The loan is not returned to accrual status until the debtor has demonstrated the ability to continue debt service in accordance with the contractual terms. Loans placed on non-accrual status will be accounted for on a cash basis, in which income is recognized only upon the receipt of cash, or on a cost-recovery basis, in which all cash receipts reduce the carrying value of the loan, based on the Company's expectation of future collectability.

The Company had one mortgage note receivable outstanding as of September 30, 2017 and December 31, 2016 with a principal balance of $10.6 million and $10.9 million, respectively. Principal and interest are due monthly based on a 20-year amortization schedule, with a balloon payment due at maturity on September 30, 2026. At September 30, 2017 and December 31, 2016, approximately $336,000 and $87,000, respectively, in interest was due from the borrower and is included in other assets on our Condensed Consolidated Balance Sheets, of which approximately $253,000 and $0, respectively, was past due in accordance the terms of the underlying note.

The borrower and several related entities filed for voluntary bankruptcy on June 23, 2017. Upon filing for bankruptcy, the borrower was current on all obligations to the Company but no payments have been received during the bankruptcy. The Company has evaluated the collectability of the mortgage note which included an evaluation of the loan collateral, and based on information currently available, has determined that no impairment is required. As a result of the loan's past due status and the related circumstances surrounding the loan, the Company will continue to closely review the circumstances and reserve against accrued interest as needed based on events as they occur. The Company will continue to evaluate the collectability of the note as additional information becomes available.

The Company may receive loan or commitment fees upon the funding of a mortgage note. The Company will amortize those fees into income over the life of the mortgage note on a straight-line basis and will reflect the mortgage note, net of the unamortized fees, on its Consolidated Balance Sheet.

Stock-Based Compensation

The Company's 2014 Incentive Plan, as amended, (our "2014 Incentive Plan"), is intended to attract and retain qualified persons upon whom, in large measure, our sustained progress, growth and profitability depend, to motivate the participants to achieve long-term company goals and to more closely align the participants’ interests with those of our other stockholders by providing them with a proprietary interest in our growth and performance. The three distinct programs under the 2014 Incentive Plan are the Amended and Restated Alignment of Interest Program, the Amended and Restated Executive Officer Incentive Program and the Non-Executive Officer Incentive Program. Our executive officers, officers, employees, consultants and non-employee directors are eligible to participate in the 2014 Incentive Plan. The 2014 Incentive Plan increases, on an annual basis, the number of shares of common stock available for issuance to an amount equal to 7% of the total number of shares of the Company’s common stock

12

Notes to Condensed Consolidated Financial Statements - Continued

outstanding on December 31 of the immediately preceding year. The 2014 Incentive Plan is administered by the Company’s compensation committee, which interprets the 2014 Incentive Plan and has broad discretion to select the eligible persons to whom awards will be granted, as well as the type, size and terms and conditions of each award, including the number of shares subject to awards and the expiration date of, and the vesting schedule or other restrictions (including, without limitation, restrictive covenants) applicable to, awards. The Company recognizes share-based payments to its directors and employees in its Condensed Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date.

Intangible Assets

Intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present.

Identifiable intangible assets of the Company are generally comprised of in-place lease intangible assets, above- and below-market lease intangibles and deferred financing costs. In-place lease intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Deferred financing costs are amortized to interest expense over the term of the related credit facility or other debt instrument using the straight-line method, which approximates the effective interest method.

Contingent Liabilities

From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or under-insured damages.

Management will monitor any matter that may present a contingent liability, and, on a quarterly basis, will review any reserves and accruals relating to the liabilities, adjusting provisions as necessary based on changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss will be reflected as adjustments to the related liability in the periods when they occur and will be disclosed in the notes to the Condensed Consolidated Financial Statements.

On occasion, the Company may also have acquisitions which include contingent consideration. In 2016, the Company acquired a medical office building and concurrently recorded the fair value of contingent purchase price of approximately $0.5 million. Subsequently, management monitored this contingency and adjusted its liability to its estimated fair value on a quarterly basis, offsetting property operating expense in the periods when they occurred. In April 2017, the Company paid approximately $0.4 million in settlement of this contingent liability.

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). We have also elected for one of our subsidiaries to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has made provisions for federal and state income taxes for the TRS. The Company intends at all times to qualify as a REIT under Sections 856 and 860 of the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a real estate investment trust.

The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses.

Sales and Use Taxes

13

Notes to Condensed Consolidated Financial Statements - Continued

The Company must pay sales and use taxes to certain state tax authorities based on rent collected from tenants in properties located in those states. The Company is generally reimbursed for those taxes by those tenants. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis, included in tenant reimbursement revenue on the Company’s Condensed Consolidated Statements of Income.

Concentration of Credit Risks

Our credit risks primarily relate to cash and cash equivalents, our mortgage note receivable and our interest rate swaps, which are discussed below. Cash and cash equivalents are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that often exceed federally-insured limits. We have not experienced any losses in such accounts.

Derivative Financial Instruments

In the normal course of business, we are subject to risk from adverse fluctuations in interest rates. We have chosen to manage this risk through the use of derivative financial instruments, or interest rate swaps. Counterparties to these contracts are major financial institutions. We are exposed to credit loss in the event of nonperformance by these counterparties. We do not use derivative instruments for trading or speculative purposes. Our objective in managing exposure to market risk is to limit the impact on cash flows. To qualify for hedge accounting, our interest rate swaps must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions must be, and be expected to remain, probable of occurring in accordance with our related assertions. All of our hedges are cash flow hedges and are recognized at their fair value in the Condensed Consolidated Balance Sheets. Changes in the fair value of the derivatives are recognized in accumulated other comprehensive loss.

Earnings per Share

Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the non-vested shares of common stock using the treasury stock method and the average stock price during the period.

New Accounting Pronouncements

On July 1, 2017, the Company adopted the Financial Accounting Standard Board's ("FASB") ASU No. 2017-12, Derivatives and Hedging Topic 815: Targeted Improvements to Accounting for Hedging Activities, ("ASU 2017-12"). ASU 2017-12 is intended to better align an entity’s financial reporting for hedging activities with the economic objectives of those activities. Upon adoption of ASU 2017-12, the cumulative ineffectiveness that a company had previously recognized on existing cash flow and net investment hedges is adjusted and removed from beginning retained earnings and placed in accumulated other comprehensive income. The adoption of ASU 2017-12 did not have an impact on our financial statements as we had not previously recognized any hedge ineffectiveness related to our existing cash flow hedges. In future periods, for hedges that are deemed highly effective, we will no longer need to recognize any hedge ineffectiveness, and all gains or losses will be recognized in other comprehensive income.

In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Lease components will continue to be recognized on a straight-line basis over the lease term and certain non-lease components will be accounted for under the new revenue recognition guidance in the Revenue ASUs. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.

14

Notes to Condensed Consolidated Financial Statements - Continued

Between May 2014 and May 2016, the FASB issued three ASUs changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), (ii) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”) and (iii) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 defers the effective date of ASU 2014-09 by one year to fiscal years, and interim periods within, beginning after December 15, 2017. The Company intends on adopting the Revenue ASUs on January 1, 2018. A reporting entity may apply the amendments in the Revenue ASUs using either a modified retrospective approach, by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or full retrospective approach.

The primary source of revenue for the Company is generated through leasing arrangements, which are excluded from the Revenue ASUs. However, we expect that the recognition of non-lease revenue will be impacted due to the principle versus agent considerations in the Revenue ASUs that will become effective upon the adoption of ASU 2016-02 on January 1, 2019. Also, under ASU 2014-09, revenue recognition for real estate sales is largely based on the transfer of control versus continuing involvement under current guidance. The Company has not yet elected a transition method and is evaluating the complete impact of the adoption of the Revenue ASUs on January 1, 2018 to its consolidated financial position, results of operations and disclosures. The Company expects to complete its overall evaluation of the impact of the Revenue ASUs during the fourth quarter of 2017, with continued evaluations during 2018 of the impact to its non-lease revenue upon adoption of ASU 2016-02 in 2019.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, ("ASU 2016-13"), which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, ("ASU 2016-15"), which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. This new standard is effective for the Company on January 1, 2018 with early adoption permitted. Of the eight areas addressed, the Company expects that its presentation on its statements of cash flows could be impacted relating to cash payments of contingent consideration or settlement of insurance claims, based on historical transactions. In the future, however, the impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's cash flows or its results of operations.

In May 2017, the FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718), ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are

15

Notes to Condensed Consolidated Financial Statements - Continued

the same as the original award immediately before the award is modified. This standard is effective for the Company on January 1, 2018 with early adoption permitted. The Company does not believe the adoption of this standard will have an impact on its results of operations, but could impact the accounting on future modifications of share-based awards.

16

Note 2. Real Estate Investments

At September 30, 2017, the Company had investments of approximately $358.0 million in 80 real estate properties, including a mortgage note. The following table summarizes the Company's real estate investments.

(Dollars in thousands)	Number of Facilities	Land and Land Improvements		Buildings, Improvements, and Lease Intangibles		Personal Property		Total		Accumulated Depreciation
Medical office buildings:
Florida	4	$	4,138	$	23,777	$	—	$	27,915	$	2,168
Ohio	5	3,167		23,518		—		26,685		2,912
Texas	3	3,096		12,315		—		15,411		2,950
Kansas	2	1,427		10,497		—		11,924		2,317
Iowa	1	2,241		8,979		—		11,220		885
Illinois	2	1,134		11,791		—		12,925		1,374
Virginia	1	369		4,649		—		5,018		156
Other states	13	3,273		22,695		—		25,968		1,970
	31	18,845		118,221		—		137,066		14,732
Physician clinics:
Kansas	3	1,638		10,899		—		12,537		1,780
Florida	3	—		5,950		—		5,950		462
Illinois	1	1,891		3,134		—		5,025		31
Other states	9	3,195		18,461		—		21,656		2,719
	16	6,724		38,444		—		45,168		4,992
Surgical centers and hospitals:
Louisiana	1	1,683		21,353		—		23,036		444
Indiana	1	523		14,405		—		14,928		188
Michigan	2	628		8,272		—		8,900		1,713
Illinois	1	2,183		5,410		—		7,593		634
Florida	1	271		7,004		—		7,275		118
Arizona	2	576		5,389		—		5,965		874
Other states	5	1,555		11,001		—		12,556		2,675
	13	7,419		72,834		—		80,253		6,646
Specialty centers:
Alabama	3	415		4,417		—		4,832		1,170
Nevada	1	276		4,402		—		4,678		183
Kentucky	1	193		3,432		—		3,625		732
Other states	10	1,716		15,227		—		16,943		1,786
	15	2,600		27,478		—		30,078		3,871
Behavioral facilities:
West Virginia	1	2,138		22,897		—		25,035		7
Illinois	1	1,300		18,803		—		20,103		627
Ohio	1	514		4,153		—		4,667		52
Indiana	1	270		2,651		—		2,921		127
	4	4,222		48,504		—		52,726		813
Corporate property	—	—		2,011		112		2,123		99
Total owned properties	79	$	39,810	$	307,492	$	112	$	347,414	$	31,153
Mortgage note receivable, net	1	—		—		—		10,633		—
Total real estate investments	80	$	39,810	$	307,492	$	112	$	358,047	$	31,153

17

Notes to Condensed Consolidated Financial Statements - Continued

Note 3. Real Estate Leases

The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2033. The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and additional rent, which may include taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.

Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of September 30, 2017, are as follows (in thousands):

2017	$	8,292
2018	30,409
2019	27,202
2020	24,497
2021	21,541
2022 and thereafter	134,018
	$	245,959

Note 4. Real Estate Acquisitions

Property Acquisitions

During the third quarter of 2017, the Company acquired two real estate properties totaling approximately 147,000 square feet for an aggregate purchase price and cash consideration of approximately $28.3 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2022 through 2032. In addition, we funded a $5.0 million mezzanine loan to the tenant of one of the properties. Amounts reflected in revenues and net income for the three months ended September 30, 2017 for these properties was approximately $44,000 and $31,000, respectively. Transaction costs totaling approximately $65,000 related to these acquisitions were capitalized in the period as part of the real estate assets and approximately $11,000 was expensed related to the mezzanine loan.

During the second quarter of 2017, the Company acquired 10 real estate properties totaling approximately 203,000 square feet for an aggregate purchase price of approximately $36.2 million, including cash consideration of approximately $35.9 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2019 through 2032. Amounts reflected in revenues and net income for the nine months ended September 30, 2017 for these properties was approximately $1.3 million and $0.6 million, respectively. Transaction costs totaling approximately $0.3 million related to these acquisitions were capitalized in the period as part of the real estate assets.

During the first quarter of 2017, the Company acquired 10 real estate properties totaling approximately 145,000 square feet for an aggregate purchase price of approximately $28.5 million, including cash consideration of approximately $28.4 million. Upon acquisition, the properties were 95.2% leased in the aggregate with lease expirations ranging from 2018 through 2032. Amounts reflected in revenues and net income for the nine months ended September 30, 2017 for these properties was approximately $1.9 million and $0.5 million, respectively. Transaction costs totaling approximately $0.4 million related to these acquisitions were capitalized in the period as part of the real estate assets. During the first quarter of 2017, the Company also acquired a property, adjacent to its corporate office, for a cash purchase price of approximately $0.9 million. The property is currently leased to a tenant but the Company intends to use the property for future expansion of its corporate office.

18

Notes to Condensed Consolidated Financial Statements - Continued

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed in the property acquisitions for the nine months ended September 30, 2017.

	Estimated Fair Value			Estimated Useful Life
	(In thousands)			(In years)
Land and land improvements	$	9,715		5 - 7.5
Building and building improvements	74,891			20 - 40
Intangibles:
In place lease intangibles	9,527			1.4 - 8.9
Total intangibles	9,527
Accounts receivable and other assets assumed	32
Accounts payable, accrued liabilities and other liabilities assumed (1)	(416		)
Prorated rent, interest and operating expense reimbursement amounts collected	(307		)
Total cash consideration	$	93,442
(1) Includes security deposits received.

Note 5. Debt, net

The table below details the Company's debt as of September 30, 2017 and December 31, 2016.

	Balance as of
(Dollars in thousands)	September 30,  2017		December 31, 2016		Maturity Dates
Revolving Credit Facility	$	—	$	51,000	8/19
5-Year Term Loan, net	29,648		—		3/22
7-Year Term Loan, net	29,636		—		3/24
	$	59,284	$	51,000

On March 29, 2017, we entered into a second amended and restated Credit Facility (as amended and restated, the "Credit Facility"). The Credit Facility is by and among Community Healthcare OP, LP, the Company, the Lenders from time to time party thereto, and SunTrust Bank, as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Credit Facility provides for a $150.0 million revolving credit facility (the "Revolving Credit Facility") and $100.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $450.0 million, including the ability to add and fund additional term loans. The Revolving Credit Facility matures on August 9, 2019 and includes two 12-month options to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five-year term loan facility in the aggregate principal amount of $50.0 million (the "5-Year Term Loan") which matures on March 29, 2022 and a seven-year term loan facility in the aggregate principal amount of $50.0 million (the "7-Year Term Loan") which matures on March 29, 2024. Upon closing of the Credit Facility on March 29, 2017, the Company borrowed $30.0 million under each of the 5-Year Term Loan and the 7-Year Term Loan. Each of the 5-Year Term Loan and 7-Year Term Loan has a delayed draw feature that is available in up to three draws within 15 months from March 29, 2017, subject to a minimum draw of $10.0 million and pro forma compliance. The Company incurred approximately $784,000 in fees and other costs upon closing of the Credit Facility which are netted against the term loans and are being amortized to interest expense on a straight-line basis which approximates the effective interest method.

19

Notes to Condensed Consolidated Financial Statements - Continued

Amounts outstanding under the Revolving Credit Facility bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.75% to 2.75% or (ii) a base rate plus 0.75% to 1.75%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. At September 30, 2017, the Company had no balance outstanding under the Revolving Credit Facility with a remaining borrowing capacity of $150.0 million.

Amounts outstanding under the Term Loans bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 2.2% to 2.9% or (ii) a base rate plus 1.25% to 1.9%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company entered into interest rate swaps to fix the interest rates on the term loans as discussed in Note 6. At September 30, 2017, the Company had $60.0 million outstanding under the Term Loans with a fixed weighted average interest rate under the swaps of approximately 4.34% and remaining borrowing capacity of $40.0 million.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, the Company’s present financing policy prohibits incurring debt (secured or unsecured) in excess of 40% of its total book capitalization. The Company was in compliance with its financial covenants under its Credit Facility at September 30, 2017.

Note 6. Derivative Financial Instruments

Risk Management Objective of Using Derivatives

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and/or caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract.

As of September 30, 2017, the Company had two outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $60.0 million. The Company had recorded the fair value of its interest rate derivatives totaling approximately $386,000 in other liabilities in its Condensed Consolidated Balance Sheet.

20

Notes to Condensed Consolidated Financial Statements - Continued

The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive loss and is subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings.

Amounts reported in accumulated other comprehensive loss related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $0.3 million will be reclassified from other comprehensive income ("OCI") as an increase to interest expense.

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and nine months ended September 30, 2017.

(Dollars in thousands)	Three Months Ended September 30, 2017			Nine Months Ended September 30, 2017
Amount of gain (loss) recognized in OCI on derivative	$	(74	)	$	(672	)
Amount of gain (loss) reclassified from accumulated OCI into interest expense	$	(124	)	$	(286	)
Total Interest (Expense) presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	1,091		$	2,897

Credit-risk-related Contingent Features

As of September 30, 2017, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $0.4 million. As of September 30, 2017, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately $0.4 million at September 30, 2017.

Note 7. Stockholders’ Equity

Common Stock

The following table provides a reconciliation of the beginning and ending common stock balances for the nine months ended September 30, 2017 and for the year ended December 31, 2016:

	Nine Months Ended September 30, 2017	Year Ended December 31, 2016
Balance, beginning of period	12,988,482	7,596,940
Issuance of common stock	4,887,500	5,175,000
Restricted stock-based awards	209,816	216,542
Balance, end of period	18,085,798	12,988,482

Equity Offering

On July 26, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.9 million after deducting underwriting discount and commissions and estimated offering expenses payable by the Company.

Proceeds from the offering were used to repay the outstanding balance on our revolving credit facility totaling $58.0 million and for investments during the third and fourth quarters of 2017.

21

Notes to Condensed Consolidated Financial Statements - Continued

Universal Shelf S-3 Registration Statement

On September 13, 2016, the Company filed a registration statement on Form S-3 that allows us to offer debt or equity securities (or a combination thereof) of up to $750.0 million from time to time. The Form S-3 registration statement was declared effective as of September 26, 2016. In July 2017, the Company completed an equity offering and issued approximately 4,887,500 shares of its common stock for gross proceeds of approximately $114.6 million under its Form S-3 registration statement, resulting in approximately $635.4 million remaining to be issued under the Form S-3 registration statement.

Note 8. Net Income Per Common Share

The following table sets forth the computation of basic and diluted net income per common share.

	Three Months Ended September 30, 2017						Nine Months Ended September 30, 2017
(Dollars in thousands, except per share data)	2017			2016			2017			2016
Net income	$	579		$	1,064		$	1,958		$	1,688
Participating securities' share in earnings	(200		)	—			(526		)	—
Net income, less participating securities' share in earnings	$	379		$	1,064		$	1,432		$	1,688
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	16,719,150			12,948,097			14,319,231			10,972,011
Unvested restricted stock	(477,164		)	(261,914		)	(434,755		)	(219,678		)
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333
Dilutive potential common shares	—			64,784			—			49,762
Weighted average Common Shares outstanding –Diluted	16,241,986			12,750,967			13,884,476			10,802,095
Basic Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16
Diluted Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16

Note 9. Incentive Plan

Under the Company's 2014 Incentive Plan, awards may be made in the form of restricted stock, cash or a combination of both. Compensation expense recognized from the amortization of the value of the Company's officer, employee and director shares over the applicable vesting periods during the three months ended September 30, 2017 and 2016 was approximately $0.4 million and $0.2 million, respectively, and during the nine months ended September 30, 2017 and 2016 was approximately $1.1 million and $0.5 million, respectively.

22

A summary of the activity under the 2014 Incentive Plan for the three and nine months ended September 30, 2017 and 2016 is included in the table below.

		Three Months Ended September 30,		Nine Months Ended September 30,
		2017	2016	2017	2016
Stock-based awards, beginning of period		434,980	224,895	302,299	85,757
	Stock in lieu of compensation	16,452	38,703	80,580	104,110
	Stock awards	60,683	38,701	129,236	112,432
	Total stock granted	77,135	77,404	209,816	216,542
Stock-based awards, end of period		512,115	302,299	512,115	302,299

Note 10. Other Assets

Other assets consists primarily of notes receivable, accounts receivable, straight-line rent receivables, prepaid assets, deferred financing costs, and above-market intangible assets. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2017 and December 31, 2016 are detailed in the table below.

	Balance as of
(Dollars in thousands)	September 30, 2017			December 31, 2016
Notes receivable	$	5,704		$	—
Accounts receivable	1,918			2,472
Straight-line rent receivables	1,723			744
Allowance for doubtful accounts	(293		)	(154		)
Prepaid assets	355			260
Deferred financing costs, net	716			1,010
Above-market intangible assets, net	—			25
Other	653			486
	$	10,776		$	4,843

Note 11. Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value.

Cash and cash equivalents - The carrying amount approximates the fair value.

Mortgage note receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company.

Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company.

Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates.

23

The table below details the fair values and carrying values for our mortgage note and notes receivable at September 30, 2017 and December 31, 2016, using Level 2 inputs.

	September 30, 2017				December 31, 2016
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Mortgage note receivable	$	10,633	$	10,633	$	10,786	$	10,786
Notes receivable	$	5,704	$	5,669	$	—	$	—

Note 12. Subsequent Events

Dividend Declared

On November 2, 2017, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.395 per share. The dividend is payable on December 1, 2017 to stockholders of record on November 17, 2017.

Property Acquisitions

During the fourth quarter of 2017, through November 7, 2017, the Company acquired three real estate properties totaling approximately 105,500 square feet for an aggregate purchase price and cash consideration of approximately $25.9 million. Upon acquisition, the properties were 100% leased with lease expirations ranging from 2025 through 2032. These acquisitions were funded with net proceeds remaining from the Company's July 2017 equity offering and from the Company's Revolving Credit Facility.

24

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Disclosure Regarding Forward-Looking Statements

This report and other materials that Community Healthcare Trust Incorporated (the "Company") has filed or may file with the Securities and Exchange Commission, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain, contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, the Company's Quarterly Reports on Form 10-Q for the three months ended March 31, 2017 and June 30, 2017, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this report and the Company undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.

The purpose of this Management's Discussion and Analysis ("MD&A") is to provide an understanding of the Company's consolidated financial condition, results of operations and cash. MD&A is provided as a supplement to, and should be read in conjunction with, the Company's Condensed Consolidated Financial Statements and accompanying notes.

Overview

References such as "we," "us," "our," and "the Company" mean Community Healthcare Trust Incorporated, a Maryland corporation, and its consolidated subsidiaries, including Community Healthcare OP, LP, a Delaware limited partnership of which we are the sole general partner (the "OP").

We were organized in the State of Maryland on March 28, 2014. We are a self-administered, self-managed healthcare real estate investment trust, or REIT, that acquires and owns properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by the OP, either directly or through subsidiaries. The Company is the sole general partner, owning 100% of the OP units.

25

Trends and Matters Impacting Operating Results

Management will monitor factors and trends that it believes are important to the Company and the REIT industry in order to gauge their potential impact on the operations of the Company. Certain of the factors and trends that management believes may impact the operations of the Company are discussed below.

Property acquisitions

During the third quarter of 2017, the Company acquired two real estate properties totaling approximately 147,000 square feet for an aggregate purchase price and cash consideration of approximately $28.3 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2022 through 2032. In addition, we funded a $5.0 million mezzanine loan to the tenant of one of the properties.

During the second quarter of 2017, the Company acquired 10 real estate properties totaling approximately 203,000 square feet for an aggregate purchase price of approximately $36.2 million, including cash consideration of approximately $35.9 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2019 through 2032.

During the first quarter of 2017, the Company acquired ten real estate properties totaling approximately 145,000 square feet for an aggregate purchase price of approximately $28.5 million, including cash consideration of approximately $28.4 million. Upon acquisition, the properties were approximately 95.2% leased in the aggregate with lease expirations ranging from 2018 through 2032. During the first quarter of 2017, the Company also acquired a property, adjacent to its corporate office, for a cash purchase price of approximately $0.9 million. The property is currently leased to a tenant but the Company intends to use the property for future expansion of its corporate office.

See Note 4 to the Condensed Consolidated Financial Statements for more details on these acquisitions.

Subsequent acquisitions

During the fourth quarter of 2017, through November 7, 2017, the Company acquired three real estate properties totaling approximately 105,500 square feet for an aggregate purchase price and cash consideration of approximately $25.9 million. Upon acquisition, the properties were 100% leased with lease expirations ranging from 2025 through 2032. These acquisitions were funded with net proceeds remaining from the Company's July 2017 equity offering and from the Company's Revolving Credit Facility.

Acquisition Pipeline

The Company has four properties under definitive purchase agreements for an aggregate expected purchase price of approximately $20.3 million. The Company's expected return on these investments range from approximately 9% to 10.5%. The Company anticipates these properties will close during the fourth quarter.  However, the Company is currently performing due diligence procedures customary for these types of transactions and cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company also has three properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $40.4 million. The Company expects to close on one of these properties sometime in the first half of 2018 and expects to close on the remaining two properties sometime in the second half of 2018. The Company's expected aggregate return on these investments ranges up to approximately 11%.  However, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company anticipates funding these investments with cash from operations, through proceeds from its Credit Facility or from net proceeds from additional debt or equity offerings.

26

Leased square footage

As of September 30, 2017, our real estate portfolio was approximately 92.1% leased. During the third quarter of 2017, we had expiring or terminated leases related to approximately 40,000 square feet and leased or renewed leases relating to approximately 20,000 square feet.

Equity Offering

On July 26, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.9 million after deducting underwriting discount and commissions and estimated offering expenses payable by the Company.

Proceeds from the offering were used to repay the outstanding balance on our revolving credit facility totaling $58.0 million and for investments during the third and fourth quarters of 2017.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that are reasonably likely to have a material effect on the Company's consolidated financial condition, results of operations or liquidity.

Inflation

We believe inflation will have a minimal impact on the operating performance of our properties. Many of our lease agreements contain provisions designed to mitigate the adverse impact of inflation. These provisions include clauses that enable us to receive payment of increased rent pursuant to escalation clauses which generally increase rental rates during the terms of the leases. These escalation clauses often provide for fixed rent increases or indexed escalations (based upon the Consumer Price Index or other measures). However, some of these contractual rent increases may be less than the actual rate of inflation. Generally, our lease agreements require the tenant to pay property operating expenses, including maintenance costs, real estate taxes and insurance. This requirement reduces our exposure to increases in these costs and property operating expenses resulting from inflation.

Seasonality

We do not expect our business to be subject to material seasonal fluctuations.

New Accounting Pronouncements

See Note 1 to the Company’s Condensed Consolidated Financial Statements accompanying this report for information on new accounting standards not yet adopted.

27

Results of Operations

The Company's results of operations for the three months ended September 30, 2017 compared to the same period in 2016 have most significantly been impacted by its real estate acquisitions. As of September 30, 2017 and 2016, the Company had investments in real estate properties, including a mortgage note, totaling approximately $358.0 million and $217.6 million, respectively.

Three Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016

The table below shows our results of operations for the three months ended September 30, 2017 compared to the same period in 2016 and the effect of changes in those results from period to period on our net income.

	Three Months Ended September 30,						Increase (Decrease) to Net Income
(dollars in thousands)	2017			2016			$
REVENUES
Rental income	$	8,012		$	4,985		$	3,027
Tenant reimbursements	1,158			1,188			(30		)
Mortgage interest	255			270			(15		)
Other operating	19			—			19
	9,444			6,443			3,001
EXPENSES
Property operating	2,225			963			(1,262		)
General and administrative	1,069			671			(398		)
Depreciation and amortization	4,544			3,496			(1,048		)
Bad debts	—			73			73
	7,838			5,203			(2,635		)
OTHER INCOME (EXPENSE)
Interest expense	(1,091		)	(185		)	(906		)
Interest and other income, net	64			9			55
	(1,027		)	(176		)	(851		)
NET INCOME	$	579		$	1,064		$	(485	)

Revenues

Our revenues for the three months ended September 30, 2017 and 2016 totaling approximately $9.4 million and $6.4 million, respectively, represented income generated from our investments in 80 and 52 real estate properties and mortgage notes, respectively. Revenues generally include contractual rents and late fees due under the leases with our tenants, as well as straight-line rent adjustments and estimated operating expense recoveries under our tenant leases, and mortgage interest related to our mortgage notes receivable. The increase in rental income for the three months ended September 30, 2017 compared to the same period in 2016 was substantially related to properties acquired since June 30, 2016.

Expenses

Our expenses for the three months ended September 30, 2017 and 2016 totaling approximately $7.8 million and $5.2 million, respectively, generally represented expenses related to our real estate properties, general and administrative expenses, depreciation and amortization expense, and bad debt expense.

28

• Property operating expenses included expenses incurred related to our owned real estate properties and generally include real estate taxes and insurance, utilities, repairs and maintenance and other operating expenses of the properties. Property operating expenses for the three months ended September 30, 2017 compared to the same period in 2016 increased approximately $0.6 million related to properties acquired since June 30, 2016. Property operating expenses for the remaining portfolio increased approximately $0.2 million for the three months ended September 30, 2017 compared to the same period in 2016. Property operating expenses for the three months ended September 30, 2016 were also reduced by approximately $0.5 million due to net fair value adjustments of the contingent purchase price initially recognized upon the acquisition of three properties in 2016.

• General and administrative expenses generally included legal, regulatory, and accounting fees, as well as certain compensation-related and occupancy costs related to its officers, employees and corporate office. Compensation-related expenses increased approximately $0.3 million for the three months ended September 30, 2017 compared to the same period in 2016. General and administrative expenses for the three months ended September 30, 2016 also included approximately $0.1 million in closing expenses related to the Company's acquisitions while in 2017 the Company included closing costs as part of the purchase price for its acquisitions upon the adoption of ASU No, 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, which is discussed in more detail in Note 1 to our Condensed Consolidated Financial Statements.

• Depreciation and amortization generally included depreciation on its buildings and improvements, as well as amortization of intangible assets resulting from the acquisition of its real estate properties, Depreciation and amortization for the three months ended September 30, 2017 compared to the same period in 2016 increased approximately $1.6 million related to properties acquired since June 30, 2016 while certain intangible assets became fully depreciated resulting in a decrease of approximately $0.6 million.

• During the three months ended September 30, 2016, the Company recognized approximately $73,000 in bad debt expense related to four tenants. No bad debt expense was recognized during the three months ended September 30, 2017.

Interest expense

Interest expense for the three months ended September 30, 2017 compared to the same period in 2016 increased approximately $0.9 million. In the first quarter of 2017, the Company entered into its Credit Facility, as amended and restated, and borrowed $60 million in Term Loans, resulting in additional interest expense of approximately $0.7 million during the three months ended September 30, 2017 compared to the same period in 2016. In addition, the balance outstanding on our Revolving Credit Facility was higher during the three months ended September 30, 2017 compared to the same period in 2016 resulting in additional interest expense of approximately $0.2 million.

29

Nine Months EndedSeptember 30, 2017 Compared to Nine Months EndedSeptember 30, 2016

The table below shows our results of operations for the nine months ended September 30, 2017 compared to the same period in 2016 and the effect of changes in those results from period to period on our net income.

	Nine Months Ended September 30,						Increase (Decrease) to Net Income
(dollars in thousands)	2017			2016			$
REVENUES
Rental income	$	21,968		$	13,188		$	8,780
Tenant reimbursements	3,620			3,250			370
Mortgage interest	774			1,367			(593		)
Other operating	19			—			19
	26,381			17,805			8,576
EXPENSES
Property operating	6,103			3,240			(2,863		)
General and administrative	2,674			2,372			(302		)
Depreciation and amortization	12,749			9,643			(3,106		)
Bad debts	67			103			36
	21,593			15,358			(6,235		)
OTHER INCOME (EXPENSE)
Interest expense	(2,897		)	(787		)	(2,110		)
Interest and other income, net	67			28			39
	(2,830		)	(759		)	(2,071		)
NET INCOME	$	1,958		$	1,688		$	270

Revenues

Our revenues for the nine months ended September 30, 2017 and 2016 totaling approximately $26.4 million and $17.8 million, respectively, represented income generated from our investments in 80 and 52 real estate properties and mortgage notes, respectively. Revenues generally include contractual rents and late fees due under the leases with our tenants, as well as straight-line rent adjustments and estimated operating expense recoveries under our tenant leases, and mortgage interest related to our mortgage notes receivable.

• Rental income for the nine months ended September 30, 2017 compared to the same period in 2016 increased approximately $7.4 million related to properties acquired since June 30, 2016. The remaining increase is mostly due to rent increases, straight-line rent and additional leasing on the remaining portfolio.

• Tenant reimbursements for the nine months ended September 30, 2017 compared to the same period in 2016 increased approximately $0.6 million related to properties acquired since June 30, 2016, partially offset by decreases in current and prior year reconciliations.

• Mortgage interest decreased approximately $0.6 million for the nine months ended September 30, 2017 compared to the same period in 2016 due to interest recorded during 2016 related to a $12.5 million mortgage note that the Company funded in the first quarter of 2016 and then converted to real estate upon the acquisition of the property in the second quarter of 2016.

30

Expenses

Our expenses for the nine months ended September 30, 2017 and 2016 totaling approximately $21.6 million and $15.4 million, respectively, generally represented expenses related to our real estate properties, general and administrative expenses, depreciation and amortization expense, and bad debt expense.

• Property operating expenses included expenses incurred related to our owned real estate properties and generally include real estate taxes and insurance, utilities, repairs and maintenance and other operating expenses of the properties. Property operating expenses for the nine months ended September 30, 2017 compared to the same period in 2016 increased approximately $1.3 million related to properties acquired since June 30, 2016. Maintenance and repairs and management fees for the remaining portfolio increased approximately $0.4 million for the nine months ended September 30, 2017 compared to the same period in 2016. Property operating expenses for the nine months ended September 30, 2016 were also reduced by approximately $1.0 million due to net fair value adjustments of the contingent purchase price initially recognized upon the acquisition of three properties in 2016.

• General and administrative expenses generally included legal, regulatory, and accounting fees, as well as certain compensation-related and occupancy costs related to its officers, employees and corporate office. Compensation-related expenses increased approximately $0.5 million for the nine months ended September 30, 2017 compared to the same period in 2016. General and administrative expenses for the nine months ended September 30, 2016 also included approximately $0.6 million in closing expenses related to the Company's acquisitions while in 2017 the Company included closing costs as part of the purchase price for its acquisitions upon the adoption of ASU No, 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, which is discussed in more detail in Note 1 to our Condensed Consolidated Financial Statements. Other legal, regulatory and accounting fees increased approximately $0.4 million for the nine months ended September 30, 2017 compared to the same period in 2016.

• Depreciation and amortization generally included depreciation on its buildings and improvements, as well as amortization of intangible assets resulting from the acquisition of its real estate properties. Depreciation and amortization for the nine months ended September 30, 2017 compared to the same period in 2016 increased approximately $3.6 million related to properties acquired since June 30, 2016 and increased approximately $0.5 million related to the remaining portfolio, while certain intangible assets became fully depreciated resulting in a decrease of approximately $1.0 million.

Interest expense

Interest expense for the nine months ended September 30, 2017 compared to the same period in 2016 increased approximately $2.1 million. In the first quarter of 2017, the Company entered into its Credit Facility, as amended, and borrowed $60 million in Term Loans, resulting in additional interest expense of approximately $1.5 million during the nine months ended September 30, 2017 compared to the same period in 2016. In addition, in April 2016, the Company completed a follow-on public offering of 5,175,000 shares of its common stock and received $86.8 million from the offering which was partially used to repay the outstanding balance on its revolving credit facility. The Company had no borrowings on its Revolving Credit Facility throughout the second or third quarters of 2016, until the last day of the third quarter, resulting in lower interest expense in 2016 of approximately $0.6 million.

31

Funds from Operations

Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to “net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus depreciation and amortization related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures.”

Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO and FFO per share can facilitate comparisons of operating performance between periods. The Company reports FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share. However, FFO does not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO should not be considered as an alternative to net income attributable to common stockholders as an indicator of the Company’s operating performance or as an alternative to cash flow from operating activities as a measure of liquidity. The table below reconciles FFO to net income for the three and nine months ended September 30, 2017 and 2016, respectively.

	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars in thousands, excepts per share amounts)	2017		2016		2017		2016
Net income	$	579	$	1,064	1,958		$	1,688
Real estate depreciation and amortization	4,539		3,493		12,736		9,637
Total adjustments	4,539		3,493		12,736		9,637
Funds from Operations	$	5,118	$	4,557	$	14,694	$	11,325
Funds from Operations per Common Share-Basic	$	0.32	$	0.36	$	1.06	$	1.05
Funds from Operations per Common Share-Diluted	$	0.31	$	0.36	$	1.05	$	1.05
Weighted Average Common Shares Outstanding-Basic	16,241,986		12,686,183		13,884,476		10,752,333
Weighted Average Common Shares Outstanding-Diluted	16,401,718		12,750,967		14,035,185		10,802,095

32

Liquidity and Capital Resources

The Company monitors its liquidity and capital resources and relies on several key indicators in its assessment of capital markets for financing acquisitions and other operating activities as needed, including the following:

• Leverage ratios and financial covenants included in our Credit Facility;

• Dividend payout percentage; and

• Interest rates, underlying treasury rates, debt market spreads and equity markets.

The Company uses these indicators and others to compare its operations to its peers and to help identify areas in which the Company may need to focus its attention.

Sources and Uses of Cash

The Company derives most of its revenues from its real estate property and mortgage note portfolio, collecting rental income, operating expense reimbursements and mortgage interest based on contractual arrangements with its tenants and borrowers. These sources of revenue represent our primary source of liquidity to fund our dividends, general and administrative expenses, property operating expenses, interest expense on our Credit Facility and other expenses incurred related to managing our existing portfolio and investing in additional properties. To the extent additional resources are needed, the Company will fund its investment activity generally through equity or debt issuances either in the public or private markets or through proceeds from our Credit Facility.

The Company expects to meet its liquidity needs through cash on hand, cash flows from operations and cash flows from sources discussed above. The Company believes that its liquidity and sources of capital are adequate to satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs.

On March 29, 2017, we entered into our second amended and restated Credit Facility which provides for a $150.0 million Revolving Credit Facility and $100.0 million in Term Loans. The Credit Facility, through the accordion feature, allows borrowings up to a total of $450.0 million, including the ability to add and fund additional term loans. The Revolving Credit Facility matures on August 9, 2019 and includes two 12-month options to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five-year term loan facility in the aggregate principal amount of $50.0 million which matures on March 29, 2022 and a seven-year term loan facility in the aggregate principal amount of $50.0 million which matures on March 29, 2024. Upon closing of the Credit Facility on March 29, 2017, the Company borrowed $30.0 million under each of the 5-Year Term Loan and the 7-Year Term Loan. Each of the 5-Year Term Loan and 7-Year Term Loan has a delayed draw feature that is available in up to three draws within 15 months from March 29, 2017, subject to a minimum draw of $10.0 million and pro forma compliance. The Company entered into interest rate swaps to fix the interest rates on each of the Term Loans. At September 30, 2017, the Company had no balance outstanding under the Revolving Credit Facility with a remaining borrowing capacity of $150.0 million; and had $60.0 million outstanding under the Term Loans with a fixed weighted average interest rate under the swaps of approximately 4.34% and a remaining borrowing capacity of $40.0 million. Our debt to total book capitalization ratio was approximately 17.1% at September 30, 2017.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, our present financing policy prohibits incurring debt (secured or unsecured) in excess of 40% of our total book capitalization. At September 30, 2017, the Company was in compliance with its financial covenants under the Credit Facility.

33

Subsequent Acquisitions

During the fourth quarter of 2017, through November 7, 2017, the Company acquired three real estate properties totaling approximately 105,500 square feet for an aggregate purchase price and cash consideration of approximately $25.9 million. Upon acquisition, the properties were 100% leased with lease expirations ranging from 2025 through 2032. These acquisitions were funded with net proceeds remaining from the Company's July 2017 equity offering and from the Company's Revolving Credit Facility. See Note 7 in the Company's Condensed Consolidated Financial Statements.

Acquisition Pipeline

The Company has four properties under definitive purchase agreements for an aggregate expected purchase price of approximately $20.3 million. The Company's expected return on these investments range from approximately 9% to 10.5%. The Company anticipates these properties will close during the fourth quarter.  However, the Company is currently performing due diligence procedures customary for these types of transactions and cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company also has three properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $40.4 million. The Company expects to close on one of these properties sometime in the first half of 2018 and expects to close on the remaining two properties sometime in the second half of 2018. The Company's expected aggregate return on these investments ranges up to approximately 11%.  However, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company anticipates funding these investments with cash from operations, through proceeds from its Credit Facility or from net proceeds from additional debt or equity offerings.

Equity Offering

On July 26, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.9 million after deducting underwriting discount and commissions and estimated offering expenses payable by the Company.

Proceeds from the offering were used to repay the outstanding balance on our Revolving Credit Facility totaling $58.0 million and for investments during the third and fourth quarters of 2017.

Universal Shelf S-3 Registration Statement

On September 13, 2016, the Company filed a registration statement on Form S-3 that will allow us to offer debt or equity securities (or a combination thereof) of up to $750.0 million from time to time. The Form S-3 registration statement was declared effective as of September 26, 2016. During July 2017, the Company completed an equity offering, discussed in more detail in Note 10, and issued approximately 4,887,500 shares of its common stock for gross proceeds of approximately $114.6 million under its Form S-3 registration statement, resulting in approximately $635.4 million remaining to be issued under the Form S-3 registration statement.

Operating Activities

Cash flows provided by operating activities for the nine months ended September 30, 2017 and 2016 were approximately $15.4 million and $10.8 million, respectively. Cash flows provided by operating activities were generally provided by contractual rents, net of expenses, on our real estate property portfolio.

34

Investing Activities

Cash flows used in investing activities for the nine months ended September 30, 2017 and 2016 were approximately $98.7 million and $71.8 million, respectively. During the nine months ended September 30, 2017, the Company invested in 22 properties for an aggregate purchase price of approximately $93.0 million, including approximately $92.6 million in cash consideration. The Company also acquired a property, adjacent to its corporate office, for a cash purchase price of approximately $0.9 million. The property is currently leased to a tenant but the Company intends to use the property for future expansion of its corporate office. During the nine months ended September 30, 2016, the Company invested in 11 properties for an aggregate purchase price of approximately $71.1 million, including approximately $58.8 million in cash consideration, including transaction costs incurred, and the conversion of a $12.5 million mortgage note that the Company had funded during the first quarter of 2016.

Financing Activities

Cash flows provided by financing activities for the nine months ended September 30, 2017 and 2016 were approximately $99.2 million and $60.7 million, respectively. During the nine months ended September 30, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.9 million after deducting underwriting discount and commissions and estimated offering expenses payable by the Company. The net proceeds from the equity offering were partially used to repay $58.0 million outstanding under the Company's Revolving Credit Facility. Also, the Company entered into its Credit Facility, borrowing $60.0 million in Term Loans, and paid $17.3 million in dividends.

During the nine months ended September 30, 2016, the Company completed a public offering of 5,175,000 shares of its common stock, including 675,000 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $86.1 million after underwriting discount and commissions and estimated offering expenses payable by the Company. The Company also paid $12.8 million in dividends during the nine months ended September 30, 2016.

Security Deposits

As of September 30, 2017, the Company held approximately $2.1 million in security deposits for the benefit of the Company in the event the obligated tenant fails to perform under the terms of its respective lease. Generally, the Company may, at its discretion and upon notification to the tenant, draw upon the security deposits if there are any defaults under the leases.

Dividends

The Company is required to pay dividends to its stockholders at least equal to 90% of its taxable income in order to maintain its qualification as a REIT.

On November 2, 2017, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.3950 per share. The dividend is payable on December 1, 2017 to stockholders of record on November 17, 2017. This rate equates to an annualized dividend of $1.58 per share.

On September 1, 2017, 2017, the Company paid a cash dividend in the amount of $0.3925 per share to stockholders of record on August 28, 2017. This rate equates to an annualized dividend of $1.57 per share.

On May 4, 2017, the Company paid a cash dividend in the amount of $0.39 per share to stockholders of record on May 19, 2017. This rate equates to an annualized dividend of $1.56 per share.

35

On March 3, 2017, the Company paid a cash dividend in the amount of $0.3875 per share to shareholders of record on February 17, 2017. This rate equates to an annual dividend of $1.55 per share.

The ability of the Company to pay dividends is dependent upon its ability to generate cash flows and to make accretive new investments.

36

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

Our future income, cash flows and fair values relevant to financial instruments are dependent upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. We may use certain derivative financial instruments to manage, or hedge, interest rate risks related to our borrowings. We will not use derivatives for trading or speculative purposes and only enter into contracts with major financial institutions based upon their credit rating and other factors. An interest rate swap is a contractual agreement entered into by two counterparties under which each agrees to make periodic payments to the other for an agreed period of time based on a notional amount of principal. Under the most common form of interest rate swap, known from our perspective as a floating-to-fixed interest rate swap, a series of floating, or variable, rate payments on a notional amount of principal is exchanged for a series of fixed interest rate payments on such notional amount.

In March 2017, we entered into our Credit Facility which provides for $100.0 million in variable rate Term Loans. Upon closing of the Credit Facility, we borrowed $60.0 million in the aggregate on the Term Loans, with a delayed draw feature for the remaining $40.0 million, and subsequently entered into interest rate swaps to fix the interest rates on the Term Loans. See Notes 5, 6 and 10 for more information on the Term Loans and interest rate swaps.

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Based on this evaluation, Company’s management has concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports it files or submits under the Exchange Act.

Changes In Internal Control Over Financial Reporting

There were no changes in our system of internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

The Company may, from time to time, be involved in litigation arising in the ordinary course of business or which may be expected to be covered by insurance. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

ITEM 1A.    RISK FACTORS

In addition to the other information set forth in this quarterly report, an investor should consider the risk factors included in its Annual Report on Form 10-K for the year ended December 31, 2016, its Quarterly Reports on Form 10-Q for the three months ended June 30, 2017 and March 31, 2017, and other reports that may be filed by the Company.

37

ITEM 2.   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.   DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.   MINE SAFETY DISCLOSURES

None.

ITEM 5.   OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

The exhibits required by Item 601 of Regulation S-X which are filed with this report are listed in the Exhibit Index and are hereby incorporated in by reference.

38

EXHIBIT INDEX

Exhibit Number	Description
3.1	Corporate Charter of Community Healthcare Trust Incorporated, as amended (1)
3.2	Bylaws of Community Healthcare Trust Incorporated, as amended (2)
10.1	Amendment No. 2 to the 2014 Incentive Plan of Community Healthcare Trust Incorporated (3)
10.2	Amendment No. 3 to the 2014 Incentive Plan of Community Healthcare Trust Incorporated (4)
10.3	Underwriting Agreement, dated July 20, 2017, by and among Community Healthcare Trust Incorporated, Community Healthcare OP, LP, Sandler O’Neill & Partners, L.P., Evercore Group L.L.C. and SunTrust Robinson Humphrey, Inc., as representatives of the underwriters named in Schedule A of the Underwriting Agreement (5)
31.1 *	Certification of the Chief Executive Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
31.2 *	Certification of the Chief Financial Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
32.1 **	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Labels Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

(1) Filed as Exhibit 3.1 to Amendment No. 2 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission on May 6, 2015 (Registration No. 333-203210)and incorporated herein by reference.

(2) Filed as Exhibit 3.2 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission on April 2, 2015 (Registration No. 333-203210)and incorporated herein by reference.

(3) Filed as Exhibit 10.1 to the Form 8-K of the Company filed with the Securities and Exchange Commission on July 17, 2017.

(4) Filed as Exhibit 10.2 to the Form 8-K of the Company filed with the Securities and Exchange Commission on July 17, 2017.

(5) Filed as Exhibit 1.1 to the Form 8-K of the Company filed with the Securities and Exchange Commission on July 26, 2017.

_________

* Filed herewith.

** Furnished herewith.

39

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 7, 2017

COMMUNITY HEALTHCARE TRUST INCORPORATED
By:	/s/ Timothy G. Wallace
	Timothy G. Wallace
	Chief Executive Officer and President
By:	/s/ W. Page Barnes
	W. Page Barnes
	Executive Vice President and Chief Financial Officer

40

EX-31.1

Exhibit 31.1

Community Healthcare Trust Incorporated

Quarterly Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Timothy G. Wallace, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report, any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 7, 2017

/s/ Timothy G. Wallace

Timothy G. Wallace

Chief Executive Officer and President

EX-31.2

Exhibit 31.2

Community Healthcare Trust Incorporated

Quarterly Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, W. Page Barnes, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report, any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 7, 2017

/s/ W. Page Barnes

W. Page Barnes

Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

Community Healthcare Trust Incorporated

Certification Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated (the "Company") for the period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy G. Wallace, Chief Executive Officer and President of the Company, and I, W. Page Barnes, Executive Vice President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 7, 2017

/s/ Timothy G. Wallace

Timothy G. Wallace

Chief Executive Officer and President

/s/ W. Page Barnes

W. Page Barnes

Executive Vice President and Chief Financial Officer

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 31, 2017
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Entity Registrant Name	Community Healthcare Trust Inc
Entity Central Index Key	0001631569
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		18,085,798

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Real estate properties
Land and land improvements	$ 39,810	$ 29,884
Buildings, improvements, and lease intangibles	307,492	222,755
Personal property	112	97
Total real estate properties	347,414	252,736
Less accumulated depreciation	(31,153)	(18,404)
Total real estate properties, net	316,261	234,332
Cash and cash equivalents	17,479	1,568
Mortgage note receivable, net	10,633	10,786
Other assets, net	10,776	4,843
Total assets	355,149	251,529
Liabilities
Debt, net	59,284	51,000
Accounts payable and accrued liabilities	3,226	3,541
Other liabilities	4,743	2,981
Total liabilities	67,253	57,522
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,085,798 and 12,988,482 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	181	130
Additional paid-in capital	323,877	214,323
Cumulative net income	3,223	1,265
Accumulated other comprehensive loss	(386)	0
Cumulative dividends	(38,999)	(21,711)
Total stockholders’ equity	287,896	194,007
Total liabilities and stockholders' equity	$ 355,149	$ 251,529

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized	50,000,000	50,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized	450,000,000	450,000,000
Common Stock, shares issued	18,085,798	12,988,482
Common Stock, shares outstanding	18,085,798	12,988,482

XML

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
REVENUES
Rental income	$ 8,012	$ 4,985	$ 21,968	$ 13,188
Tenant reimbursements	1,158	1,188	3,620	3,250
Mortgage interest	255	270	774	1,367
Other operating	19	0	19	0
Revenues	9,444	6,443	26,381	17,805
EXPENSES
Property operating	2,225	963	6,103	3,240
General and administrative	1,069	671	2,674	2,372
Depreciation and amortization	4,544	3,496	12,749	9,643
Bad debts	0	73	67	103
Expenses	7,838	5,203	21,593	15,358
OTHER INCOME (EXPENSE)
Interest expense	(1,091)	(185)	(2,897)	(787)
Interest and other income, net	64	9	67	28
Other Income (Expense)	(1,027)	(176)	(2,830)	(759)
NET INCOME	$ 579	$ 1,064	$ 1,958	$ 1,688
NET INCOME PER COMMON SHARE:
Net income per common share – Basic (in dollars per share)	$ 0.02	$ 0.08	$ 0.10	$ 0.16
Net income per common share – Diluted (in dollars per share)	$ 0.02	$ 0.08	$ 0.10	$ 0.16
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)	16,241,986	12,686,183	13,884,476	10,752,333
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)	16,241,986	12,750,967	13,884,476	10,802,095
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD (in dollars per share)	$ 0.3925	$ 0.3825	$ 1.17	$ 1.14

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 579	$ 1,064	$ 1,958	$ 1,688
Other comprehensive income (loss):
Unrealized losses on cash flow hedges	(74)	0	(672)	0
Reclassification of loss amounts recognized as interest expense	124	0	286	0
Total other comprehensive income (loss)	50	0	(386)	0
COMPREHENSIVE INCOME	$ 629	$ 1,064	$ 1,572	$ 1,688

XML

Condensed Consolidated Statements of Stockholders' Equity - 9 months ended Sep. 30, 2017 - USD ($) $ in Thousands	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]	Cumulative Net Income [Member]	Accumulated Other Comprehensive Loss [Member]	Cumulative Dividends [Member]
Beginning Balance at Dec. 31, 2016	$ 194,007	$ 0	$ 130	$ 214,323	$ 1,265	$ 0	$ (21,711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock Issued During Period, Value, New Issues	108,555		49	108,506
Stock-based compensation	1,050		2	1,048
Unrecognized loss on cash flow hedges	(672)					(672)
Reclassification adjustment for losses included in net income (interest expense)	286					286
Net income	1,958				1,958
Dividends to common stockholders ($1.17 per share)	(17,288)						(17,288)
Ending Balance at Sep. 30, 2017	$ 287,896	$ 0	$ 181	$ 323,877	$ 3,223	$ (386)	$ (38,999)

XML

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)	9 Months Ended
	Sep. 30, 2017 $ / shares
Cumulative Dividends [Member]
Dividends to common stockholders, per share (in dollars per share)	$ 1.17

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Statement of Cash Flows [Abstract]
Net income	$ 1,958	$ 1,688
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	13,053	9,749
Stock-based compensation	1,050	453
Straight-line rent receivable	(980)	(405)
Straight-line rent liability	27	0
Provision for bad debts, net of recoveries	67	103
Reduction in contingent purchase price	(5)	(974)
Changes in operating assets and liabilities:
Other assets	(636)	(1,284)
Accounts payable and accrued liabilities	(404)	1,732
Other liabilities	1,234	(262)
Net cash provided by operating activities	15,364	10,800
INVESTING ACTIVITIES
Acquisitions of real estate	(93,442)	(58,249)
Funding of notes receivable	(5,000)	(12,406)
Proceeds from the repayment of notes receivable	296	0
Capital expenditures on existing real estate properties	(545)	(1,123)
Net cash used in investing activities	(98,691)	(71,778)
FINANCING ACTIVITIES
Net repayments on revolving credit facility	(51,000)	(12,000)
Term loan borrowings	60,000	0
Dividends paid	(17,288)	(12,782)
Net proceeds from issuance of common stock	109,168	86,805
Equity issuance costs	(465)	(680)
Debt issuance costs	(784)	(641)
Settlement of contingent purchase price	(393)	0
Net cash provided by financing activities	99,238	60,702
Increase (decrease) in cash and cash equivalents	15,911	(276)
Cash and cash equivalents, beginning of period	1,568	2,018
Cash and cash equivalents, end of period	17,479	1,742
Supplemental Cash Flow Information:
Interest paid	2,390	504
Invoices accrued for construction, tenant improvement and other capitalized costs	3	145
Reclassification between accounts and notes receivable	615	0
Reclassification of Registration Statement Costs Incurred In Prior Year to Equity Issuance Costs	148	0
Conversion of mortgage note upon acquisition of real estate property	0	12,500
Decrease in fair value of cash flow hedges	$ (672)	$ 0

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Business Overview

Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by its operating partnership (the "OP"), either directly or through subsidiaries. The Company is the sole general partner of the OP, owning 100% of the OP units. As of September 30, 2017, the Company had investments of approximately $358.0 million in 80 real estate properties, including a mortgage note, located in 26 states, totaling approximately 1.8 million square feet in the aggregate.

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2017.

Principles of Consolidation

Our Condensed Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, and may also include joint ventures, partnerships and variable interest entities, or VIEs, where the Company controls the operating activities. All material intercompany accounts and transactions have been eliminated.

Management must make judgments regarding the Company's level of influence or control over an entity and whether or not the Company is the primary beneficiary of a VIE. Consideration of various factors include, but is not limited to, the Company's ability to direct the activities that most significantly impact the entity's governing body, the size and seniority of the Company's investment, and the Company's ability to replace the manager and/or liquidate the entity. Management's ability to correctly assess its influence or control over an entity when determining the primary beneficiary of a VIE affects the presentation of these entities in the Company's Condensed Consolidated Financial Statements. If it is determined that the Company is the primary beneficiary of a VIE, the Company's Condensed Consolidated Financial Statements would include the operating results of the VIE rather than the results of the variable interest in the VIE. Untimely or inaccurate financial information provided to the Company or deficiencies in the VIEs internal control over financial reporting could impact the Company's Condensed Consolidated Financial Statements and its own internal control over financial reporting.

During the third quarter of 2017, concurrent with the acquisition of a property, the Company entered into a $5.0 million note receivable with the tenant in the building. See Note 4. The Company identified the borrower as a VIE, but management determined that the Company was not the primary beneficiary of the VIE because we lack either directly or through related parties any material impact in the activities that impact its economic performance.

We are not obligated to provide support beyond our stated commitment to the borrower, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding note receivable as noted above.

Jumpstart Our Business Startups Act of 2012

The Company has elected the "emerging growth company" status as permitted under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The Company elected to "opt out" of the provision allowed under the JOBS Act to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. As a result, we must comply with new or revised accounting standards as required when they are adopted. Our decision to opt out of the extended transition period under the JOBS Act is irrevocable.

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Segment Reporting

The Company acquires and owns healthcare-related real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single segment.

Cash and Cash Equivalents

Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased.

Accounting for Real Estate Property Acquisitions

Real estate property acquisitions are accounted for as a business combination or an asset acquisition. An acquisition accounted for as a business combination is recorded at fair value and related closing costs are expensed. An acquisition accounted for as an asset acquisition is recorded at its purchase price, inclusive of acquisition costs, which is allocated among the acquired assets and assumed liabilities based upon their relative fair values at the date of acquisition. The Company adopted Accounting Standards Update ("ASU") No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, on January 1, 2017, and Company expects that substantially all of its acquisitions will be accounted for as asset acquisitions.

The allocation of real estate property acquisitions may include land and land improvements, building and building improvements, personal property, and identified intangible assets and liabilities (consisting of above- and below-market leases, in-place leases, and tenant relationships) based on the evaluation of information and estimates available at that date, and we allocate the purchase price based on these assessments. We make estimates of the acquisition date fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence, tax records, and other sources. Based on these estimates, we recognize the acquired assets and liabilities at their estimated fair values. We expense transaction costs associated with business combinations in the period incurred. The fair value of tangible property assets acquired considers the value of the property as if vacant determined by comparable sales and other relevant data. The determination of fair value involves the use of significant judgment and estimation. We value land based on various inputs, which may include internal analysis of recently acquired properties, existing comparable properties within our portfolio, or third party appraisals or valuations based on comparable sales.

In recognizing identified intangible assets and liabilities of an acquired property, the value of above- or below-market leases is estimated based on the present value (using a discount rate which reflects the risks associated with the leases acquired) of the difference between contractual amounts to be received pursuant to the leases and management’s estimate of market lease rates measured over a period equal to the estimated remaining term of the lease. In the case of a below-market lease, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The capitalized above-market or below-market lease intangibles are amortized as a reduction from or an addition to rental income over the estimated remaining term of the respective leases.

In determining the value of in-place leases and tenant relationships, management considers current market conditions and costs to execute similar leases in arriving at an estimate of the carrying costs during the expected lease-up period from vacant to existing occupancy. In estimating carrying costs, management includes real estate taxes, insurance, other property operating expenses, estimates of lost rental revenue during the expected lease-up periods, and costs to execute similar leases, including leasing commissions. The values assigned to in-place leases and tenant relationships are amortized over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.

Depreciation and amortization of real estate assets and liabilities in place as of September 30, 2017, is recognized on a straight-line basis over the estimated useful life of the asset. The estimated useful lives at September 30, 2017 are as follows:

Land improvements	3 - 15 years
Buildings	20 - 40 years
Building improvements	3.0 - 39.8 years
Tenant improvements	2.3 - 6.9 years
Lease intangibles	1.4 - 13.7 years
Personal property	3 -10 years

Asset Impairments

The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant under-performance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its operators. In addition, the Company’s review for possible impairment may include those assets subject to purchase options and those impacted by casualties, such as tornadoes and hurricanes. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property.

Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements.

A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

• Level 1 – quoted prices for identical instruments in active markets;

• Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

• Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Our interest rate swaps are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as Level 2 in the hierarchy.

Lease Accounting

We, as a lessor, make a determination with respect to each of our leases whether they should be accounted for as operating leases or capital leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic useful life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. We believe all of our leases meet the accounting criteria to be accounted for as operating leases. Payments received under operating leases are accounted for in the Condensed Consolidated Statements of Income as rental revenue for actual cash rent collected plus or minus straight-line adjustments resulting from lease escalators. Assets subject to operating leases are reported as real estate investments in the Condensed Consolidated Balance Sheets.

Substantially all of our leases contain fixed or formula-based rent escalators. To the extent that the escalators are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

Revenue Recognition

The Company recognizes rental revenue when it is realized or realizable and earned. There are four criteria that must be met before a company may recognize revenue, including persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered (i.e., the tenant has taken possession of and controls the physical use of the leased asset), the price has been fixed or is determinable, and collectability is reasonably assured.

The Company derives most of its revenues from its real estate and mortgage note portfolio. The Company's rental and interest income is recognized based on contractual arrangements with its tenants and borrowers.

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue in amounts more or less than amounts currently due from tenants. If management determines that the collectability of straight-line rents is not reasonably assured, the amount of future revenue recognized may be limited to amounts contractually owed and, where appropriate, establish an allowance for estimated losses. Straight-line rent included in rental income was approximately $0.4 million and $0.2 million, respectively, for the three months ended September 30, 2017 and 2016 and $1.0 million and $0.4 million, respectively, for the nine months ended September 30, 2017 and 2016.

Interest income is recognized based on the interest rates, maturity dates and amortization periods set forth within each note agreement. Fees received related to our mortgage note are amortized to mortgage interest income on a straight-line basis which approximates amortization under the effective interest method.

Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities, was approximately $0.9 million and $0.8 million, respectively, at September 30, 2017 and December 31, 2016.

Allowance for Doubtful Accounts and Credit Losses

Accounts Receivable

Management monitors the aging and collectability of its accounts receivable balances on an ongoing basis. Whenever deterioration in the timeliness of payment from a tenant is noted, management investigates and determines the reason or reasons for the delay. Considering all information gathered, management’s judgment is exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage may be uncollectible. Among the factors management considers in determining collectability are: the type of contractual arrangement under which the receivable was recorded (e.g., triple net lease, gross lease, or other type of agreement); the tenant’s reason for slow payment; industry influences under which the tenant operates; evidence of willingness and ability of the tenant to pay the receivable; credit-worthiness of the tenant; collateral, security deposit, letters of credit or other monies held as security; tenant’s historical payment pattern; other contractual agreements between the tenant and the Company; relationship between the tenant and the Company; the state in which the tenant operates; and the existence of a guarantor and the willingness and ability of the guarantor to pay the receivable. Considering these factors and others, management concludes whether all or some of the aged receivable balance is likely uncollectible. Upon determining that some portion of the receivable is likely uncollectible, the Company will record a provision for bad debts for the amount it expects will be uncollectible. When efforts to collect a receivable are exhausted, the receivable amount is charged off against the allowance. At September 30, 2017 and December 31, 2016, the Company had an allowance for bad debts of approximately $293,000 and $154,000, respectively.

Mortgage Note and Notes Receivable

The Company evaluates collectability of its notes receivable and records allowances as necessary. A note is impaired when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan as scheduled, including both contractual interest and principal payments. This assessment also includes an evaluation of the loan collateral. If a mortgage loan becomes past due, the Company will review the specific circumstances and may discontinue the accrual of interest on the loan. The loan is not returned to accrual status until the debtor has demonstrated the ability to continue debt service in accordance with the contractual terms. Loans placed on non-accrual status will be accounted for on a cash basis, in which income is recognized only upon the receipt of cash, or on a cost-recovery basis, in which all cash receipts reduce the carrying value of the loan, based on the Company's expectation of future collectability.

The Company had one mortgage note receivable outstanding as of September 30, 2017 and December 31, 2016 with a principal balance of $10.6 million and $10.9 million, respectively. Principal and interest are due monthly based on a 20-year amortization schedule, with a balloon payment due at maturity on September 30, 2026. At September 30, 2017 and December 31, 2016, approximately $336,000 and $87,000, respectively, in interest was due from the borrower and is included in other assets on our Condensed Consolidated Balance Sheets, of which approximately $253,000 and $0, respectively, was past due in accordance the terms of the underlying note.

The borrower and several related entities filed for voluntary bankruptcy on June 23, 2017. Upon filing for bankruptcy, the borrower was current on all obligations to the Company but no payments have been received during the bankruptcy. The Company has evaluated the collectability of the mortgage note which included an evaluation of the loan collateral, and based on information currently available, has determined that no impairment is required. As a result of the loan's past due status and the related circumstances surrounding the loan, the Company will continue to closely review the circumstances and reserve against accrued interest as needed based on events as they occur. The Company will continue to evaluate the collectability of the note as additional information becomes available.

The Company may receive loan or commitment fees upon the funding of a mortgage note. The Company will amortize those fees into income over the life of the mortgage note on a straight-line basis and will reflect the mortgage note, net of the unamortized fees, on its Consolidated Balance Sheet.

Stock-Based Compensation

The Company's 2014 Incentive Plan, as amended, (our "2014 Incentive Plan"), is intended to attract and retain qualified persons upon whom, in large measure, our sustained progress, growth and profitability depend, to motivate the participants to achieve long-term company goals and to more closely align the participants’ interests with those of our other stockholders by providing them with a proprietary interest in our growth and performance. The three distinct programs under the 2014 Incentive Plan are the Amended and Restated Alignment of Interest Program, the Amended and Restated Executive Officer Incentive Program and the Non-Executive Officer Incentive Program. Our executive officers, officers, employees, consultants and non-employee directors are eligible to participate in the 2014 Incentive Plan. The 2014 Incentive Plan increases, on an annual basis, the number of shares of common stock available for issuance to an amount equal to 7% of the total number of shares of the Company’s common stock outstanding on December 31 of the immediately preceding year. The 2014 Incentive Plan is administered by the Company’s compensation committee, which interprets the 2014 Incentive Plan and has broad discretion to select the eligible persons to whom awards will be granted, as well as the type, size and terms and conditions of each award, including the number of shares subject to awards and the expiration date of, and the vesting schedule or other restrictions (including, without limitation, restrictive covenants) applicable to, awards. The Company recognizes share-based payments to its directors and employees in its Condensed Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date.

Intangible Assets

Intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present.

Identifiable intangible assets of the Company are generally comprised of in-place lease intangible assets, above- and below-market lease intangibles and deferred financing costs. In-place lease intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Deferred financing costs are amortized to interest expense over the term of the related credit facility or other debt instrument using the straight-line method, which approximates the effective interest method.

Contingent Liabilities

From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or under-insured damages.

Management will monitor any matter that may present a contingent liability, and, on a quarterly basis, will review any reserves and accruals relating to the liabilities, adjusting provisions as necessary based on changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss will be reflected as adjustments to the related liability in the periods when they occur and will be disclosed in the notes to the Condensed Consolidated Financial Statements.

On occasion, the Company may also have acquisitions which include contingent consideration. In 2016, the Company acquired a medical office building and concurrently recorded the fair value of contingent purchase price of approximately $0.5 million. Subsequently, management monitored this contingency and adjusted its liability to its estimated fair value on a quarterly basis, offsetting property operating expense in the periods when they occurred. In April 2017, the Company paid approximately $0.4 million in settlement of this contingent liability.

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). We have also elected for one of our subsidiaries to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has made provisions for federal and state income taxes for the TRS. The Company intends at all times to qualify as a REIT under Sections 856 and 860 of the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a real estate investment trust.

The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses.

Sales and Use Taxes

The Company must pay sales and use taxes to certain state tax authorities based on rent collected from tenants in properties located in those states. The Company is generally reimbursed for those taxes by those tenants. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis, included in tenant reimbursement revenue on the Company’s Condensed Consolidated Statements of Income.

Concentration of Credit Risks

Our credit risks primarily relate to cash and cash equivalents, our mortgage note receivable and our interest rate swaps, which are discussed below. Cash and cash equivalents are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that often exceed federally-insured limits. We have not experienced any losses in such accounts.

Derivative Financial Instruments

In the normal course of business, we are subject to risk from adverse fluctuations in interest rates. We have chosen to manage this risk through the use of derivative financial instruments, or interest rate swaps. Counterparties to these contracts are major financial institutions. We are exposed to credit loss in the event of nonperformance by these counterparties. We do not use derivative instruments for trading or speculative purposes. Our objective in managing exposure to market risk is to limit the impact on cash flows. To qualify for hedge accounting, our interest rate swaps must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions must be, and be expected to remain, probable of occurring in accordance with our related assertions. All of our hedges are cash flow hedges and are recognized at their fair value in the Condensed Consolidated Balance Sheets. Changes in the fair value of the derivatives are recognized in accumulated other comprehensive loss.

Earnings per Share

Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the non-vested shares of common stock using the treasury stock method and the average stock price during the period.

New Accounting Pronouncements

On July 1, 2017, the Company adopted the Financial Accounting Standard Board's ("FASB") ASU No. 2017-12, Derivatives and Hedging Topic 815: Targeted Improvements to Accounting for Hedging Activities, ("ASU 2017-12"). ASU 2017-12 is intended to better align an entity’s financial reporting for hedging activities with the economic objectives of those activities. Upon adoption of ASU 2017-12, the cumulative ineffectiveness that a company had previously recognized on existing cash flow and net investment hedges is adjusted and removed from beginning retained earnings and placed in accumulated other comprehensive income. The adoption of ASU 2017-12 did not have an impact on our financial statements as we had not previously recognized any hedge ineffectiveness related to our existing cash flow hedges. In future periods, for hedges that are deemed highly effective, we will no longer need to recognize any hedge ineffectiveness, and all gains or losses will be recognized in other comprehensive income.

In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Lease components will continue to be recognized on a straight-line basis over the lease term and certain non-lease components will be accounted for under the new revenue recognition guidance in the Revenue ASUs. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.

Between May 2014 and May 2016, the FASB issued three ASUs changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), (ii) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”) and (iii) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 defers the effective date of ASU 2014-09 by one year to fiscal years, and interim periods within, beginning after December 15, 2017. The Company intends on adopting the Revenue ASUs on January 1, 2018. A reporting entity may apply the amendments in the Revenue ASUs using either a modified retrospective approach, by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or full retrospective approach.

The primary source of revenue for the Company is generated through leasing arrangements, which are excluded from the Revenue ASUs. However, we expect that the recognition of non-lease revenue will be impacted due to the principle versus agent considerations in the Revenue ASUs that will become effective upon the adoption of ASU 2016-02 on January 1, 2019. Also, under ASU 2014-09, revenue recognition for real estate sales is largely based on the transfer of control versus continuing involvement under current guidance. The Company has not yet elected a transition method and is evaluating the complete impact of the adoption of the Revenue ASUs on January 1, 2018 to its consolidated financial position, results of operations and disclosures. The Company expects to complete its overall evaluation of the impact of the Revenue ASUs during the fourth quarter of 2017, with continued evaluations during 2018 of the impact to its non-lease revenue upon adoption of ASU 2016-02 in 2019.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, ("ASU 2016-13"), which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, ("ASU 2016-15"), which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. This new standard is effective for the Company on January 1, 2018 with early adoption permitted. Of the eight areas addressed, the Company expects that its presentation on its statements of cash flows could be impacted relating to cash payments of contingent consideration or settlement of insurance claims, based on historical transactions. In the future, however, the impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's cash flows or its results of operations.

In May 2017, the FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718), ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are the same as the original award immediately before the award is modified. This standard is effective for the Company on January 1, 2018 with early adoption permitted. The Company does not believe the adoption of this standard will have an impact on its results of operations, but could impact the accounting on future modifications of share-based awards.

XML

Real Estate Investments

9 Months Ended

Sep. 30, 2017

Real Estate [Abstract]

Real Estate Investments

Real Estate Investments

At September 30, 2017, the Company had investments of approximately $358.0 million in 80 real estate properties, including a mortgage note. The following table summarizes the Company's real estate investments.

(Dollars in thousands)	Number of Facilities	Land and Land Improvements		Buildings, Improvements, and Lease Intangibles		Personal Property		Total		Accumulated Depreciation
Medical office buildings:
Florida	4	$	4,138	$	23,777	$	—	$	27,915	$	2,168
Ohio	5	3,167		23,518		—		26,685		2,912
Texas	3	3,096		12,315		—		15,411		2,950
Kansas	2	1,427		10,497		—		11,924		2,317
Iowa	1	2,241		8,979		—		11,220		885
Illinois	2	1,134		11,791		—		12,925		1,374
Virginia	1	369		4,649		—		5,018		156
Other states	13	3,273		22,695		—		25,968		1,970
	31	18,845		118,221		—		137,066		14,732
Physician clinics:
Kansas	3	1,638		10,899		—		12,537		1,780
Florida	3	—		5,950		—		5,950		462
Illinois	1	1,891		3,134		—		5,025		31
Other states	9	3,195		18,461		—		21,656		2,719
	16	6,724		38,444		—		45,168		4,992
Surgical centers and hospitals:
Louisiana	1	1,683		21,353		—		23,036		444
Indiana	1	523		14,405		—		14,928		188
Michigan	2	628		8,272		—		8,900		1,713
Illinois	1	2,183		5,410		—		7,593		634
Florida	1	271		7,004		—		7,275		118
Arizona	2	576		5,389		—		5,965		874
Other states	5	1,555		11,001		—		12,556		2,675
	13	7,419		72,834		—		80,253		6,646
Specialty centers:
Alabama	3	415		4,417		—		4,832		1,170
Nevada	1	276		4,402		—		4,678		183
Kentucky	1	193		3,432		—		3,625		732
Other states	10	1,716		15,227		—		16,943		1,786
	15	2,600		27,478		—		30,078		3,871
Behavioral facilities:
West Virginia	1	2,138		22,897		—		25,035		7
Illinois	1	1,300		18,803		—		20,103		627
Ohio	1	514		4,153		—		4,667		52
Indiana	1	270		2,651		—		2,921		127
	4	4,222		48,504		—		52,726		813
Corporate property	—	—		2,011		112		2,123		99
Total owned properties	79	$	39,810	$	307,492	$	112	$	347,414	$	31,153
Mortgage note receivable, net	1	—		—		—		10,633		—
Total real estate investments	80	$	39,810	$	307,492	$	112	$	358,047	$	31,153

XML

Real Estate Leases

9 Months Ended

Sep. 30, 2017

Leases [Abstract]

Real Estate Leases

Real Estate Leases

The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2033. The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and additional rent, which may include taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.

Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of September 30, 2017, are as follows (in thousands):

2017	$	8,292
2018	30,409
2019	27,202
2020	24,497
2021	21,541
2022 and thereafter	134,018
	$	245,959

XML

Real Estate Acquisitions

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Real Estate Acquisitions

Real Estate Acquisitions

Property Acquisitions

During the third quarter of 2017, the Company acquired two real estate properties totaling approximately 147,000 square feet for an aggregate purchase price and cash consideration of approximately $28.3 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2022 through 2032. In addition, we funded a $5.0 million mezzanine loan to the tenant of one of the properties. Amounts reflected in revenues and net income for the three months ended September 30, 2017 for these properties was approximately $44,000 and $31,000, respectively. Transaction costs totaling approximately $65,000 related to these acquisitions were capitalized in the period as part of the real estate assets and approximately $11,000 was expensed related to the mezzanine loan.

During the second quarter of 2017, the Company acquired 10 real estate properties totaling approximately 203,000 square feet for an aggregate purchase price of approximately $36.2 million, including cash consideration of approximately $35.9 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2019 through 2032. Amounts reflected in revenues and net income for the nine months ended September 30, 2017 for these properties was approximately $1.3 million and $0.6 million, respectively. Transaction costs totaling approximately $0.3 million related to these acquisitions were capitalized in the period as part of the real estate assets.

During the first quarter of 2017, the Company acquired 10 real estate properties totaling approximately 145,000 square feet for an aggregate purchase price of approximately $28.5 million, including cash consideration of approximately $28.4 million. Upon acquisition, the properties were 95.2% leased in the aggregate with lease expirations ranging from 2018 through 2032. Amounts reflected in revenues and net income for the nine months ended September 30, 2017 for these properties was approximately $1.9 million and $0.5 million, respectively. Transaction costs totaling approximately $0.4 million related to these acquisitions were capitalized in the period as part of the real estate assets. During the first quarter of 2017, the Company also acquired a property, adjacent to its corporate office, for a cash purchase price of approximately $0.9 million. The property is currently leased to a tenant but the Company intends to use the property for future expansion of its corporate office.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed in the property acquisitions for the nine months ended September 30, 2017.

	Estimated Fair Value			Estimated Useful Life
	(In thousands)			(In years)
Land and land improvements	$	9,715		5 - 7.5
Building and building improvements	74,891			20 - 40
Intangibles:
In place lease intangibles	9,527			1.4 - 8.9
Total intangibles	9,527
Accounts receivable and other assets assumed	32
Accounts payable, accrued liabilities and other liabilities assumed (1)	(416		)
Prorated rent, interest and operating expense reimbursement amounts collected	(307		)
Total cash consideration	$	93,442
(1) Includes security deposits received.

XML

Debt, net

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Debt, net

Debt, net

The table below details the Company's debt as of September 30, 2017 and December 31, 2016.

	Balance as of
(Dollars in thousands)	September 30,  2017		December 31, 2016		Maturity Dates
Revolving Credit Facility	$	—	$	51,000	8/19
5-Year Term Loan, net	29,648		—		3/22
7-Year Term Loan, net	29,636		—		3/24
	$	59,284	$	51,000

On March 29, 2017, we entered into a second amended and restated Credit Facility (as amended and restated, the "Credit Facility"). The Credit Facility is by and among Community Healthcare OP, LP, the Company, the Lenders from time to time party thereto, and SunTrust Bank, as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Credit Facility provides for a $150.0 million revolving credit facility (the "Revolving Credit Facility") and $100.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $450.0 million, including the ability to add and fund additional term loans. The Revolving Credit Facility matures on August 9, 2019 and includes two 12-month options to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five-year term loan facility in the aggregate principal amount of $50.0 million (the "5-Year Term Loan") which matures on March 29, 2022 and a seven-year term loan facility in the aggregate principal amount of $50.0 million (the "7-Year Term Loan") which matures on March 29, 2024. Upon closing of the Credit Facility on March 29, 2017, the Company borrowed $30.0 million under each of the 5-Year Term Loan and the 7-Year Term Loan. Each of the 5-Year Term Loan and 7-Year Term Loan has a delayed draw feature that is available in up to three draws within 15 months from March 29, 2017, subject to a minimum draw of $10.0 million and pro forma compliance. The Company incurred approximately $784,000 in fees and other costs upon closing of the Credit Facility which are netted against the term loans and are being amortized to interest expense on a straight-line basis which approximates the effective interest method.

Amounts outstanding under the Revolving Credit Facility bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.75% to 2.75% or (ii) a base rate plus 0.75% to 1.75%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. At September 30, 2017, the Company had no balance outstanding under the Revolving Credit Facility with a remaining borrowing capacity of $150.0 million.

Amounts outstanding under the Term Loans bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 2.2% to 2.9% or (ii) a base rate plus 1.25% to 1.9%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company entered into interest rate swaps to fix the interest rates on the term loans as discussed in Note 6. At September 30, 2017, the Company had $60.0 million outstanding under the Term Loans with a fixed weighted average interest rate under the swaps of approximately 4.34% and remaining borrowing capacity of $40.0 million.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, the Company’s present financing policy prohibits incurring debt (secured or unsecured) in excess of 40% of its total book capitalization. The Company was in compliance with its financial covenants under its Credit Facility at September 30, 2017.

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

Risk Management Objective of Using Derivatives

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and/or caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract.

As of September 30, 2017, the Company had two outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $60.0 million. The Company had recorded the fair value of its interest rate derivatives totaling approximately $386,000 in other liabilities in its Condensed Consolidated Balance Sheet.

The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive loss and is subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings.

Amounts reported in accumulated other comprehensive loss related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $0.3 million will be reclassified from other comprehensive income ("OCI") as an increase to interest expense.

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and nine months ended September 30, 2017.

(Dollars in thousands)	Three Months Ended September 30, 2017			Nine Months Ended September 30, 2017
Amount of gain (loss) recognized in OCI on derivative	$	(74	)	$	(672	)
Amount of gain (loss) reclassified from accumulated OCI into interest expense	$	(124	)	$	(286	)
Total Interest (Expense) presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	1,091		$	2,897

Credit-risk-related Contingent Features

As of September 30, 2017, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $0.4 million. As of September 30, 2017, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately $0.4 million at September 30, 2017.

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Common Stock

The following table provides a reconciliation of the beginning and ending common stock balances for the nine months ended September 30, 2017 and for the year ended December 31, 2016:

	Nine Months Ended September 30, 2017	Year Ended December 31, 2016
Balance, beginning of period	12,988,482	7,596,940
Issuance of common stock	4,887,500	5,175,000
Restricted stock-based awards	209,816	216,542
Balance, end of period	18,085,798	12,988,482

Equity Offering

On July 26, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.9 million after deducting underwriting discount and commissions and estimated offering expenses payable by the Company.

Proceeds from the offering were used to repay the outstanding balance on our revolving credit facility totaling $58.0 million and for investments during the third and fourth quarters of 2017.

Universal Shelf S-3 Registration Statement

On September 13, 2016, the Company filed a registration statement on Form S-3 that allows us to offer debt or equity securities (or a combination thereof) of up to $750.0 million from time to time. The Form S-3 registration statement was declared effective as of September 26, 2016. In July 2017, the Company completed an equity offering and issued approximately 4,887,500 shares of its common stock for gross proceeds of approximately $114.6 million under its Form S-3 registration statement, resulting in approximately $635.4 million remaining to be issued under the Form S-3 registration statement.

XML

Net Income Per Common Share

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Net Income Per Common Share

Net Income Per Common Share

The following table sets forth the computation of basic and diluted net income per common share.

	Three Months Ended September 30, 2017						Nine Months Ended September 30, 2017
(Dollars in thousands, except per share data)	2017			2016			2017			2016
Net income	$	579		$	1,064		$	1,958		$	1,688
Participating securities' share in earnings	(200		)	—			(526		)	—
Net income, less participating securities' share in earnings	$	379		$	1,064		$	1,432		$	1,688
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	16,719,150			12,948,097			14,319,231			10,972,011
Unvested restricted stock	(477,164		)	(261,914		)	(434,755		)	(219,678		)
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333
Dilutive potential common shares	—			64,784			—			49,762
Weighted average Common Shares outstanding –Diluted	16,241,986			12,750,967			13,884,476			10,802,095
Basic Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16
Diluted Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16

XML

Incentive Plan

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Incentive Plan

Incentive Plan

Under the Company's 2014 Incentive Plan, awards may be made in the form of restricted stock, cash or a combination of both. Compensation expense recognized from the amortization of the value of the Company's officer, employee and director shares over the applicable vesting periods during the three months ended September 30, 2017 and 2016 was approximately $0.4 million and $0.2 million, respectively, and during the nine months ended September 30, 2017 and 2016 was approximately $1.1 million and $0.5 million, respectively.

A summary of the activity under the 2014 Incentive Plan for the three and nine months ended September 30, 2017 and 2016 is included in the table below.

		Three Months Ended September 30,		Nine Months Ended September 30,
		2017	2016	2017	2016
Stock-based awards, beginning of period		434,980	224,895	302,299	85,757
	Stock in lieu of compensation	16,452	38,703	80,580	104,110
	Stock awards	60,683	38,701	129,236	112,432
	Total stock granted	77,135	77,404	209,816	216,542
Stock-based awards, end of period		512,115	302,299	512,115	302,299

XML

Other Assets

9 Months Ended

Sep. 30, 2017

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Assets

Other Assets

Other assets consists primarily of notes receivable, accounts receivable, straight-line rent receivables, prepaid assets, deferred financing costs, and above-market intangible assets. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2017 and December 31, 2016 are detailed in the table below.

	Balance as of
(Dollars in thousands)	September 30, 2017			December 31, 2016
Notes receivable	$	5,704		$	—
Accounts receivable	1,918			2,472
Straight-line rent receivables	1,723			744
Allowance for doubtful accounts	(293		)	(154		)
Prepaid assets	355			260
Deferred financing costs, net	716			1,010
Above-market intangible assets, net	—			25
Other	653			486
	$	10,776		$	4,843

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2017

Fair Value of Financial Instruments [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value.

Cash and cash equivalents - The carrying amount approximates the fair value.

Mortgage note receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company.

Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company.

Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates.

The table below details the fair values and carrying values for our mortgage note and notes receivable at September 30, 2017 and December 31, 2016, using Level 2 inputs.

	September 30, 2017				December 31, 2016
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Mortgage note receivable	$	10,633	$	10,633	$	10,786	$	10,786
Notes receivable	$	5,704	$	5,669	$	—	$	—

XML

Subsequent Events

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Dividend Declared

On November 2, 2017, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.395 per share. The dividend is payable on December 1, 2017 to stockholders of record on November 17, 2017.

Property Acquisitions

During the fourth quarter of 2017, through November 7, 2017, the Company acquired three real estate properties totaling approximately 105,500 square feet for an aggregate purchase price and cash consideration of approximately $25.9 million. Upon acquisition, the properties were 100% leased with lease expirations ranging from 2025 through 2032. These acquisitions were funded with net proceeds remaining from the Company's July 2017 equity offering and from the Company's Revolving Credit Facility.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2017.

Principles of Consolidation

Principles of Consolidation

Our Condensed Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, and may also include joint ventures, partnerships and variable interest entities, or VIEs, where the Company controls the operating activities. All material intercompany accounts and transactions have been eliminated.

Use of Estimates in the Condensed Consolidated Financial Statements

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Segment Reporting

Segment Reporting

The Company acquires and owns healthcare-related real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single segment.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased.

Accounting for Real Estate Property Acquisitions

Accounting for Real Estate Property Acquisitions

Real estate property acquisitions are accounted for as a business combination or an asset acquisition. An acquisition accounted for as a business combination is recorded at fair value and related closing costs are expensed. An acquisition accounted for as an asset acquisition is recorded at its purchase price, inclusive of acquisition costs, which is allocated among the acquired assets and assumed liabilities based upon their relative fair values at the date of acquisition. The Company adopted Accounting Standards Update ("ASU") No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, on January 1, 2017, and Company expects that substantially all of its acquisitions will be accounted for as asset acquisitions.

The allocation of real estate property acquisitions may include land and land improvements, building and building improvements, personal property, and identified intangible assets and liabilities (consisting of above- and below-market leases, in-place leases, and tenant relationships) based on the evaluation of information and estimates available at that date, and we allocate the purchase price based on these assessments. We make estimates of the acquisition date fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence, tax records, and other sources. Based on these estimates, we recognize the acquired assets and liabilities at their estimated fair values. We expense transaction costs associated with business combinations in the period incurred. The fair value of tangible property assets acquired considers the value of the property as if vacant determined by comparable sales and other relevant data. The determination of fair value involves the use of significant judgment and estimation. We value land based on various inputs, which may include internal analysis of recently acquired properties, existing comparable properties within our portfolio, or third party appraisals or valuations based on comparable sales.

In recognizing identified intangible assets and liabilities of an acquired property, the value of above- or below-market leases is estimated based on the present value (using a discount rate which reflects the risks associated with the leases acquired) of the difference between contractual amounts to be received pursuant to the leases and management’s estimate of market lease rates measured over a period equal to the estimated remaining term of the lease. In the case of a below-market lease, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The capitalized above-market or below-market lease intangibles are amortized as a reduction from or an addition to rental income over the estimated remaining term of the respective leases.

In determining the value of in-place leases and tenant relationships, management considers current market conditions and costs to execute similar leases in arriving at an estimate of the carrying costs during the expected lease-up period from vacant to existing occupancy. In estimating carrying costs, management includes real estate taxes, insurance, other property operating expenses, estimates of lost rental revenue during the expected lease-up periods, and costs to execute similar leases, including leasing commissions. The values assigned to in-place leases and tenant relationships are amortized over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.

Depreciation and amortization of real estate assets and liabilities in place as of September 30, 2017, is recognized on a straight-line basis over the estimated useful life of the asset.

Asset Impairments

Asset Impairments

The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant under-performance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its operators. In addition, the Company’s review for possible impairment may include those assets subject to purchase options and those impacted by casualties, such as tornadoes and hurricanes. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property.

Fair Value Measurements

Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements.

A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

• Level 1 – quoted prices for identical instruments in active markets;

• Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

• Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Our interest rate swaps are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as Level 2 in the hierarchy.

Lease Accounting

Lease Accounting

We, as a lessor, make a determination with respect to each of our leases whether they should be accounted for as operating leases or capital leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic useful life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. We believe all of our leases meet the accounting criteria to be accounted for as operating leases. Payments received under operating leases are accounted for in the Condensed Consolidated Statements of Income as rental revenue for actual cash rent collected plus or minus straight-line adjustments resulting from lease escalators. Assets subject to operating leases are reported as real estate investments in the Condensed Consolidated Balance Sheets.

Substantially all of our leases contain fixed or formula-based rent escalators. To the extent that the escalators are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

Revenue Recognition

Revenue Recognition

The Company recognizes rental revenue when it is realized or realizable and earned. There are four criteria that must be met before a company may recognize revenue, including persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered (i.e., the tenant has taken possession of and controls the physical use of the leased asset), the price has been fixed or is determinable, and collectability is reasonably assured.

The Company derives most of its revenues from its real estate and mortgage note portfolio. The Company's rental and interest income is recognized based on contractual arrangements with its tenants and borrowers.

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue in amounts more or less than amounts currently due from tenants. If management determines that the collectability of straight-line rents is not reasonably assured, the amount of future revenue recognized may be limited to amounts contractually owed and, where appropriate, establish an allowance for estimated losses. Straight-line rent included in rental income was approximately $0.4 million and $0.2 million, respectively, for the three months ended September 30, 2017 and 2016 and $1.0 million and $0.4 million, respectively, for the nine months ended September 30, 2017 and 2016.

Interest income is recognized based on the interest rates, maturity dates and amortization periods set forth within each note agreement. Fees received related to our mortgage note are amortized to mortgage interest income on a straight-line basis which approximates amortization under the effective interest method.

Income received but not yet earned is deferred until such time it is earned.

Allowance for Doubtful Accounts and Credit Losses

Allowance for Doubtful Accounts and Credit Losses

Accounts Receivable

Management monitors the aging and collectability of its accounts receivable balances on an ongoing basis. Whenever deterioration in the timeliness of payment from a tenant is noted, management investigates and determines the reason or reasons for the delay. Considering all information gathered, management’s judgment is exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage may be uncollectible. Among the factors management considers in determining collectability are: the type of contractual arrangement under which the receivable was recorded (e.g., triple net lease, gross lease, or other type of agreement); the tenant’s reason for slow payment; industry influences under which the tenant operates; evidence of willingness and ability of the tenant to pay the receivable; credit-worthiness of the tenant; collateral, security deposit, letters of credit or other monies held as security; tenant’s historical payment pattern; other contractual agreements between the tenant and the Company; relationship between the tenant and the Company; the state in which the tenant operates; and the existence of a guarantor and the willingness and ability of the guarantor to pay the receivable. Considering these factors and others, management concludes whether all or some of the aged receivable balance is likely uncollectible. Upon determining that some portion of the receivable is likely uncollectible, the Company will record a provision for bad debts for the amount it expects will be uncollectible. When efforts to collect a receivable are exhausted, the receivable amount is charged off against the allowance. At September 30, 2017 and December 31, 2016, the Company had an allowance for bad debts of approximately $293,000 and $154,000, respectively.

Mortgage Note and Notes Receivable

The Company evaluates collectability of its notes receivable and records allowances as necessary. A note is impaired when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan as scheduled, including both contractual interest and principal payments. This assessment also includes an evaluation of the loan collateral. If a mortgage loan becomes past due, the Company will review the specific circumstances and may discontinue the accrual of interest on the loan. The loan is not returned to accrual status until the debtor has demonstrated the ability to continue debt service in accordance with the contractual terms. Loans placed on non-accrual status will be accounted for on a cash basis, in which income is recognized only upon the receipt of cash, or on a cost-recovery basis, in which all cash receipts reduce the carrying value of the loan, based on the Company's expectation of future collectability.

The Company had one mortgage note receivable outstanding as of September 30, 2017 and December 31, 2016 with a principal balance of $10.6 million and $10.9 million, respectively. Principal and interest are due monthly based on a 20-year amortization schedule, with a balloon payment due at maturity on September 30, 2026. At September 30, 2017 and December 31, 2016, approximately $336,000 and $87,000, respectively, in interest was due from the borrower and is included in other assets on our Condensed Consolidated Balance Sheets, of which approximately $253,000 and $0, respectively, was past due in accordance the terms of the underlying note.

The borrower and several related entities filed for voluntary bankruptcy on June 23, 2017. Upon filing for bankruptcy, the borrower was current on all obligations to the Company but no payments have been received during the bankruptcy. The Company has evaluated the collectability of the mortgage note which included an evaluation of the loan collateral, and based on information currently available, has determined that no impairment is required. As a result of the loan's past due status and the related circumstances surrounding the loan, the Company will continue to closely review the circumstances and reserve against accrued interest as needed based on events as they occur. The Company will continue to evaluate the collectability of the note as additional information becomes available.

The Company may receive loan or commitment fees upon the funding of a mortgage note. The Company will amortize those fees into income over the life of the mortgage note on a straight-line basis and will reflect the mortgage note, net of the unamortized fees, on its Consolidated Balance Sheet.

Stock-Based Compensation

Stock-Based Compensation

The Company's 2014 Incentive Plan, as amended, (our "2014 Incentive Plan"), is intended to attract and retain qualified persons upon whom, in large measure, our sustained progress, growth and profitability depend, to motivate the participants to achieve long-term company goals and to more closely align the participants’ interests with those of our other stockholders by providing them with a proprietary interest in our growth and performance. The three distinct programs under the 2014 Incentive Plan are the Amended and Restated Alignment of Interest Program, the Amended and Restated Executive Officer Incentive Program and the Non-Executive Officer Incentive Program. Our executive officers, officers, employees, consultants and non-employee directors are eligible to participate in the 2014 Incentive Plan. The 2014 Incentive Plan increases, on an annual basis, the number of shares of common stock available for issuance to an amount equal to 7% of the total number of shares of the Company’s common stock outstanding on December 31 of the immediately preceding year. The 2014 Incentive Plan is administered by the Company’s compensation committee, which interprets the 2014 Incentive Plan and has broad discretion to select the eligible persons to whom awards will be granted, as well as the type, size and terms and conditions of each award, including the number of shares subject to awards and the expiration date of, and the vesting schedule or other restrictions (including, without limitation, restrictive covenants) applicable to, awards. The Company recognizes share-based payments to its directors and employees in its Condensed Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date.

Intangible Assets

Intangible Assets

Intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present.

Identifiable intangible assets of the Company are generally comprised of in-place lease intangible assets, above- and below-market lease intangibles and deferred financing costs. In-place lease intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Deferred financing costs are amortized to interest expense over the term of the related credit facility or other debt instrument using the straight-line method, which approximates the effective interest method.

Contingent Liabilities

Contingent Liabilities

From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or under-insured damages.

Management will monitor any matter that may present a contingent liability, and, on a quarterly basis, will review any reserves and accruals relating to the liabilities, adjusting provisions as necessary based on changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss will be reflected as adjustments to the related liability in the periods when they occur and will be disclosed in the notes to the Condensed Consolidated Financial Statements.

On occasion, the Company may also have acquisitions which include contingent consideration. In 2016, the Company acquired a medical office building and concurrently recorded the fair value of contingent purchase price of approximately $0.5 million. Subsequently, management monitored this contingency and adjusted its liability to its estimated fair value on a quarterly basis, offsetting property operating expense in the periods when they occurred. In April 2017, the Company paid approximately $0.4 million in settlement of this contingent liability.

Income Taxes/Sales and Use Taxes

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). We have also elected for one of our subsidiaries to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has made provisions for federal and state income taxes for the TRS. The Company intends at all times to qualify as a REIT under Sections 856 and 860 of the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a real estate investment trust.

The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses.

Sales and Use Taxes

The Company must pay sales and use taxes to certain state tax authorities based on rent collected from tenants in properties located in those states. The Company is generally reimbursed for those taxes by those tenants. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis, included in tenant reimbursement revenue on the Company’s Condensed Consolidated Statements of Income.

Concentration of Credit Risks

Concentration of Credit Risks

Our credit risks primarily relate to cash and cash equivalents, our mortgage note receivable and our interest rate swaps, which are discussed below. Cash and cash equivalents are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that often exceed federally-insured limits. We have not experienced any losses in such accounts.

Derivative Financial Instruments

Derivative Financial Instruments

In the normal course of business, we are subject to risk from adverse fluctuations in interest rates. We have chosen to manage this risk through the use of derivative financial instruments, or interest rate swaps. Counterparties to these contracts are major financial institutions. We are exposed to credit loss in the event of nonperformance by these counterparties. We do not use derivative instruments for trading or speculative purposes. Our objective in managing exposure to market risk is to limit the impact on cash flows. To qualify for hedge accounting, our interest rate swaps must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions must be, and be expected to remain, probable of occurring in accordance with our related assertions. All of our hedges are cash flow hedges and are recognized at their fair value in the Condensed Consolidated Balance Sheets. Changes in the fair value of the derivatives are recognized in accumulated other comprehensive loss.

Earnings Per Share

Earnings per Share

Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the non-vested shares of common stock using the treasury stock method and the average stock price during the period.

New Accounting Pronouncements

New Accounting Pronouncements

On July 1, 2017, the Company adopted the Financial Accounting Standard Board's ("FASB") ASU No. 2017-12, Derivatives and Hedging Topic 815: Targeted Improvements to Accounting for Hedging Activities, ("ASU 2017-12"). ASU 2017-12 is intended to better align an entity’s financial reporting for hedging activities with the economic objectives of those activities. Upon adoption of ASU 2017-12, the cumulative ineffectiveness that a company had previously recognized on existing cash flow and net investment hedges is adjusted and removed from beginning retained earnings and placed in accumulated other comprehensive income. The adoption of ASU 2017-12 did not have an impact on our financial statements as we had not previously recognized any hedge ineffectiveness related to our existing cash flow hedges. In future periods, for hedges that are deemed highly effective, we will no longer need to recognize any hedge ineffectiveness, and all gains or losses will be recognized in other comprehensive income.

In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Lease components will continue to be recognized on a straight-line basis over the lease term and certain non-lease components will be accounted for under the new revenue recognition guidance in the Revenue ASUs. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.

Between May 2014 and May 2016, the FASB issued three ASUs changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), (ii) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”) and (iii) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 defers the effective date of ASU 2014-09 by one year to fiscal years, and interim periods within, beginning after December 15, 2017. The Company intends on adopting the Revenue ASUs on January 1, 2018. A reporting entity may apply the amendments in the Revenue ASUs using either a modified retrospective approach, by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or full retrospective approach.

The primary source of revenue for the Company is generated through leasing arrangements, which are excluded from the Revenue ASUs. However, we expect that the recognition of non-lease revenue will be impacted due to the principle versus agent considerations in the Revenue ASUs that will become effective upon the adoption of ASU 2016-02 on January 1, 2019. Also, under ASU 2014-09, revenue recognition for real estate sales is largely based on the transfer of control versus continuing involvement under current guidance. The Company has not yet elected a transition method and is evaluating the complete impact of the adoption of the Revenue ASUs on January 1, 2018 to its consolidated financial position, results of operations and disclosures. The Company expects to complete its overall evaluation of the impact of the Revenue ASUs during the fourth quarter of 2017, with continued evaluations during 2018 of the impact to its non-lease revenue upon adoption of ASU 2016-02 in 2019.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, ("ASU 2016-13"), which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, ("ASU 2016-15"), which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. This new standard is effective for the Company on January 1, 2018 with early adoption permitted. Of the eight areas addressed, the Company expects that its presentation on its statements of cash flows could be impacted relating to cash payments of contingent consideration or settlement of insurance claims, based on historical transactions. In the future, however, the impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's cash flows or its results of operations.

In May 2017, the FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718), ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are the same as the original award immediately before the award is modified. This standard is effective for the Company on January 1, 2018 with early adoption permitted. The Company does not believe the adoption of this standard will have an impact on its results of operations, but could impact the accounting on future modifications of share-based awards.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Schedule of property, plant, and equipment estimated useful lives

The estimated useful lives at September 30, 2017 are as follows:

Land improvements	3 - 15 years
Buildings	20 - 40 years
Building improvements	3.0 - 39.8 years
Tenant improvements	2.3 - 6.9 years
Lease intangibles	1.4 - 13.7 years
Personal property	3 -10 years

XML

Real Estate Investments (Tables)

9 Months Ended

Sep. 30, 2017

Real Estate [Abstract]

Schedule of real estate property investments

At September 30, 2017, the Company had investments of approximately $358.0 million in 80 real estate properties, including a mortgage note. The following table summarizes the Company's real estate investments.

(Dollars in thousands)	Number of Facilities	Land and Land Improvements		Buildings, Improvements, and Lease Intangibles		Personal Property		Total		Accumulated Depreciation
Medical office buildings:
Florida	4	$	4,138	$	23,777	$	—	$	27,915	$	2,168
Ohio	5	3,167		23,518		—		26,685		2,912
Texas	3	3,096		12,315		—		15,411		2,950
Kansas	2	1,427		10,497		—		11,924		2,317
Iowa	1	2,241		8,979		—		11,220		885
Illinois	2	1,134		11,791		—		12,925		1,374
Virginia	1	369		4,649		—		5,018		156
Other states	13	3,273		22,695		—		25,968		1,970
	31	18,845		118,221		—		137,066		14,732
Physician clinics:
Kansas	3	1,638		10,899		—		12,537		1,780
Florida	3	—		5,950		—		5,950		462
Illinois	1	1,891		3,134		—		5,025		31
Other states	9	3,195		18,461		—		21,656		2,719
	16	6,724		38,444		—		45,168		4,992
Surgical centers and hospitals:
Louisiana	1	1,683		21,353		—		23,036		444
Indiana	1	523		14,405		—		14,928		188
Michigan	2	628		8,272		—		8,900		1,713
Illinois	1	2,183		5,410		—		7,593		634
Florida	1	271		7,004		—		7,275		118
Arizona	2	576		5,389		—		5,965		874
Other states	5	1,555		11,001		—		12,556		2,675
	13	7,419		72,834		—		80,253		6,646
Specialty centers:
Alabama	3	415		4,417		—		4,832		1,170
Nevada	1	276		4,402		—		4,678		183
Kentucky	1	193		3,432		—		3,625		732
Other states	10	1,716		15,227		—		16,943		1,786
	15	2,600		27,478		—		30,078		3,871
Behavioral facilities:
West Virginia	1	2,138		22,897		—		25,035		7
Illinois	1	1,300		18,803		—		20,103		627
Ohio	1	514		4,153		—		4,667		52
Indiana	1	270		2,651		—		2,921		127
	4	4,222		48,504		—		52,726		813
Corporate property	—	—		2,011		112		2,123		99
Total owned properties	79	$	39,810	$	307,492	$	112	$	347,414	$	31,153
Mortgage note receivable, net	1	—		—		—		10,633		—
Total real estate investments	80	$	39,810	$	307,492	$	112	$	358,047	$	31,153

XML

Real Estate Leases (Tables)

9 Months Ended

Sep. 30, 2017

Leases [Abstract]

Schedule of future minimum lease payments for operating leases

Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of September 30, 2017, are as follows (in thousands):

2017	$	8,292
2018	30,409
2019	27,202
2020	24,497
2021	21,541
2022 and thereafter	134,018
	$	245,959

XML

Real Estate Acquisitions (Tables)

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Schedule of assets acquired and liabilities assumed

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed in the property acquisitions for the nine months ended September 30, 2017.

	Estimated Fair Value			Estimated Useful Life
	(In thousands)			(In years)
Land and land improvements	$	9,715		5 - 7.5
Building and building improvements	74,891			20 - 40
Intangibles:
In place lease intangibles	9,527			1.4 - 8.9
Total intangibles	9,527
Accounts receivable and other assets assumed	32
Accounts payable, accrued liabilities and other liabilities assumed (1)	(416		)
Prorated rent, interest and operating expense reimbursement amounts collected	(307		)
Total cash consideration	$	93,442
(1) Includes security deposits received.

XML

Debt, net (Tables)

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Schedule of debt

The table below details the Company's debt as of September 30, 2017 and December 31, 2016.

	Balance as of
(Dollars in thousands)	September 30,  2017		December 31, 2016		Maturity Dates
Revolving Credit Facility	$	—	$	51,000	8/19
5-Year Term Loan, net	29,648		—		3/22
7-Year Term Loan, net	29,636		—		3/24
	$	59,284	$	51,000

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of derivative gain (loss)

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and nine months ended September 30, 2017.

(Dollars in thousands)	Three Months Ended September 30, 2017			Nine Months Ended September 30, 2017
Amount of gain (loss) recognized in OCI on derivative	$	(74	)	$	(672	)
Amount of gain (loss) reclassified from accumulated OCI into interest expense	$	(124	)	$	(286	)
Total Interest (Expense) presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	1,091		$	2,897

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Schedule of reconciliation of common stock

The following table provides a reconciliation of the beginning and ending common stock balances for the nine months ended September 30, 2017 and for the year ended December 31, 2016:

	Nine Months Ended September 30, 2017	Year Ended December 31, 2016
Balance, beginning of period	12,988,482	7,596,940
Issuance of common stock	4,887,500	5,175,000
Restricted stock-based awards	209,816	216,542
Balance, end of period	18,085,798	12,988,482

XML

Net Income Per Common Share (Tables)

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Schedule of earnings per share

The following table sets forth the computation of basic and diluted net income per common share.

	Three Months Ended September 30, 2017						Nine Months Ended September 30, 2017
(Dollars in thousands, except per share data)	2017			2016			2017			2016
Net income	$	579		$	1,064		$	1,958		$	1,688
Participating securities' share in earnings	(200		)	—			(526		)	—
Net income, less participating securities' share in earnings	$	379		$	1,064		$	1,432		$	1,688
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	16,719,150			12,948,097			14,319,231			10,972,011
Unvested restricted stock	(477,164		)	(261,914		)	(434,755		)	(219,678		)
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333
Dilutive potential common shares	—			64,784			—			49,762
Weighted average Common Shares outstanding –Diluted	16,241,986			12,750,967			13,884,476			10,802,095
Basic Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16
Diluted Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16

XML

Incentive Plan (Tables)

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of nonvested restricted stock activity

A summary of the activity under the 2014 Incentive Plan for the three and nine months ended September 30, 2017 and 2016 is included in the table below.

		Three Months Ended September 30,		Nine Months Ended September 30,
		2017	2016	2017	2016
Stock-based awards, beginning of period		434,980	224,895	302,299	85,757
	Stock in lieu of compensation	16,452	38,703	80,580	104,110
	Stock awards	60,683	38,701	129,236	112,432
	Total stock granted	77,135	77,404	209,816	216,542
Stock-based awards, end of period		512,115	302,299	512,115	302,299

XML

Other Assets (Tables)

9 Months Ended

Sep. 30, 2017

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Assets

Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2017 and December 31, 2016 are detailed in the table below.

	Balance as of
(Dollars in thousands)	September 30, 2017			December 31, 2016
Notes receivable	$	5,704		$	—
Accounts receivable	1,918			2,472
Straight-line rent receivables	1,723			744
Allowance for doubtful accounts	(293		)	(154		)
Prepaid assets	355			260
Deferred financing costs, net	716			1,010
Above-market intangible assets, net	—			25
Other	653			486
	$	10,776		$	4,843

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value of Financial Instruments [Abstract]

Fair Value, by Balance Sheet Grouping

The table below details the fair values and carrying values for our mortgage note and notes receivable at September 30, 2017 and December 31, 2016, using Level 2 inputs.

	September 30, 2017				December 31, 2016
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Mortgage note receivable	$	10,633	$	10,633	$	10,786	$	10,786
Notes receivable	$	5,704	$	5,669	$	—	$	—

XML

Summary of Significant Accounting Policies - Business Overview/Segment Reporting (Details) $ in Thousands, ft² in Millions	9 Months Ended
	Sep. 30, 2017 USD ($) ft² state reporting_unit real_estate_property
Accounting Policies [Abstract]
General partner ownership	100.00%
Value of real estate property investments and mortgages | $	$ 358,047
Number of real estate properties | real_estate_property	80
Number of states in which real estate investments are in | state	26
Area of real estate property (in square feet) | ft²	1.8
Number of reporting units | reporting_unit	1

XML

Summary of Significant Accounting Policies - Real Estate Properties (Details)	9 Months Ended
	Sep. 30, 2017
Land Improvements [Member] | Minimum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	3 years
Land Improvements [Member] | Maximum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	15 years
Building [Member] | Minimum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	20 years
Building [Member] | Maximum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	40 years
Building Improvements [Member] | Minimum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	3 years
Building Improvements [Member] | Maximum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	39 years 10 months
Tenant Improvements [Member] | Minimum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	2 years 4 months
Tenant Improvements [Member] | Maximum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	6 years 11 months
Lease Intangibles [Member] | Minimum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	1 year 4 months 15 days
Lease Intangibles [Member] | Maximum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	13 years 8 months
Personal Property [Member] | Minimum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	3 years
Personal Property [Member] | Maximum [Member]
Real Estate Properties [Line Items]
Estimated useful life (in years)	10 years

XML

Summary of Significant Accounting Policies - Revenue Recognition/Account and Mortgage Receivable (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017 USD ($) mortgage_note_receivable	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) mortgage_note_receivable	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($) mortgage_note_receivable
Deferred Revenue Arrangement [Line Items]
Straight line rent	$ 400	$ 200	$ 1,000	$ 400
Provision for bad debts	$ 293		$ 293		$ 154
Number of mortgage note receivables | mortgage_note_receivable	1		1
Mortgage note receivable	$ 10,633		$ 10,633		10,786
Amortization period			20 years
Other Liabilities [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue	900		$ 900		800
Other Assets [Member]
Deferred Revenue Arrangement [Line Items]
Interest receivable	336		336		87
Interest receivable considered past due	$ 253		$ 253		$ 0
Mortgage Receivable [Member]
Deferred Revenue Arrangement [Line Items]
Number of mortgage note receivables | mortgage_note_receivable	1		1		1
Mortgage note receivable	$ 10,600		$ 10,600		$ 10,900

XML

Summary of Significant Accounting Policies - Stock-Based Compensation/Contingent Liabilities (Details) $ in Thousands	1 Months Ended	9 Months Ended
	Apr. 30, 2017 USD ($)	Sep. 30, 2017 USD ($) program	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Settlement of contingent purchase price	$ 400	$ 393	$ 0
2014 Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of programs under plan | program		3
Common Stock [Member] | 2014 Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares reserved for future issuance		7.00%
Medical office [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contingent liabilities				$ 500

XML

Real Estate Investments - Additional Information (Details) $ in Thousands	Sep. 30, 2017 USD ($) real_estate_property
Real Estate [Abstract]
Value of real estate property investments and mortgages | $	$ 358,047
Number of real estate properties | real_estate_property	80

XML

Real Estate Investments - Schedule of Real Estate Property Investments (Details) $ in Thousands	Sep. 30, 2017 USD ($) mortgage_note_receivable real_estate_property	Dec. 31, 2016 USD ($)
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	80
Land and Land Improvements	$ 39,810	$ 29,884
Buildings, Improvements, and Lease Intangibles	307,492	222,755
Personal Property	112	97
Total real estate properties	347,414	252,736
Accumulated Depreciation	$ 31,153	18,404
Number of mortgage note receivables | mortgage_note_receivable	1
Mortgage note receivable, net	$ 10,633	$ 10,786
Value of real estate property investments and mortgages	$ 358,047
Medical office [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	31
Land and Land Improvements	$ 18,845
Buildings, Improvements, and Lease Intangibles	118,221
Total real estate properties	137,066
Accumulated Depreciation	$ 14,732
Medical office [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	4
Land and Land Improvements	$ 4,138
Buildings, Improvements, and Lease Intangibles	23,777
Total real estate properties	27,915
Accumulated Depreciation	$ 2,168
Medical office [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,134
Buildings, Improvements, and Lease Intangibles	11,791
Total real estate properties	12,925
Accumulated Depreciation	$ 1,374
Medical office [Member] | Iowa [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,241
Buildings, Improvements, and Lease Intangibles	8,979
Total real estate properties	11,220
Accumulated Depreciation	$ 885
Medical office [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,427
Buildings, Improvements, and Lease Intangibles	10,497
Total real estate properties	11,924
Accumulated Depreciation	$ 2,317
Medical office [Member] | Ohio [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 3,167
Buildings, Improvements, and Lease Intangibles	23,518
Total real estate properties	26,685
Accumulated Depreciation	$ 2,912
Medical office [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	13
Land and Land Improvements	$ 3,273
Buildings, Improvements, and Lease Intangibles	22,695
Total real estate properties	25,968
Accumulated Depreciation	$ 1,970
Medical office [Member] | Texas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,096
Buildings, Improvements, and Lease Intangibles	12,315
Total real estate properties	15,411
Accumulated Depreciation	$ 2,950
Medical office [Member] | Virginia [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 369
Buildings, Improvements, and Lease Intangibles	4,649
Total real estate properties	5,018
Accumulated Depreciation	$ 156
Physician clinics [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	16
Land and Land Improvements	$ 6,724
Buildings, Improvements, and Lease Intangibles	38,444
Total real estate properties	45,168
Accumulated Depreciation	$ 4,992
Physician clinics [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 0
Buildings, Improvements, and Lease Intangibles	5,950
Total real estate properties	5,950
Accumulated Depreciation	$ 462
Physician clinics [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,891
Buildings, Improvements, and Lease Intangibles	3,134
Total real estate properties	5,025
Accumulated Depreciation	$ 31
Physician clinics [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 1,638
Buildings, Improvements, and Lease Intangibles	10,899
Total real estate properties	12,537
Accumulated Depreciation	$ 1,780
Physician clinics [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	9
Land and Land Improvements	$ 3,195
Buildings, Improvements, and Lease Intangibles	18,461
Total real estate properties	21,656
Accumulated Depreciation	$ 2,719
Surgical Centers and Hospitals [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	13
Land and Land Improvements	$ 7,419
Buildings, Improvements, and Lease Intangibles	72,834
Total real estate properties	80,253
Accumulated Depreciation	$ 6,646
Surgical Centers and Hospitals [Member] | Arizona [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 576
Buildings, Improvements, and Lease Intangibles	5,389
Total real estate properties	5,965
Accumulated Depreciation	$ 874
Surgical Centers and Hospitals [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 271
Buildings, Improvements, and Lease Intangibles	7,004
Total real estate properties	7,275
Accumulated Depreciation	$ 118
Surgical Centers and Hospitals [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,183
Buildings, Improvements, and Lease Intangibles	5,410
Total real estate properties	7,593
Accumulated Depreciation	$ 634
Surgical Centers and Hospitals [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Total real estate properties	14,928
Accumulated Depreciation	$ 188
Surgical Centers and Hospitals [Member] | Louisiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,683
Buildings, Improvements, and Lease Intangibles	21,353
Total real estate properties	23,036
Accumulated Depreciation	$ 444
Surgical Centers and Hospitals [Member] | Michigan [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 628
Buildings, Improvements, and Lease Intangibles	8,272
Total real estate properties	8,900
Accumulated Depreciation	$ 1,713
Surgical Centers and Hospitals [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 1,555
Buildings, Improvements, and Lease Intangibles	11,001
Total real estate properties	12,556
Accumulated Depreciation	$ 2,675
Specialty Centers [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	15
Land and Land Improvements	$ 2,600
Buildings, Improvements, and Lease Intangibles	27,478
Total real estate properties	30,078
Accumulated Depreciation	$ 3,871
Specialty Centers [Member] | Alabama [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 415
Buildings, Improvements, and Lease Intangibles	4,417
Total real estate properties	4,832
Accumulated Depreciation	$ 1,170
Specialty Centers [Member] | Kentucky [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 193
Buildings, Improvements, and Lease Intangibles	3,432
Total real estate properties	3,625
Accumulated Depreciation	$ 732
Specialty Centers [Member] | Nevada [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 276
Buildings, Improvements, and Lease Intangibles	4,402
Total real estate properties	4,678
Accumulated Depreciation	$ 183
Specialty Centers [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	10
Land and Land Improvements	$ 1,716
Buildings, Improvements, and Lease Intangibles	15,227
Total real estate properties	16,943
Accumulated Depreciation	$ 1,786
Behavioral facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	4
Land and Land Improvements	$ 4,222
Buildings, Improvements, and Lease Intangibles	48,504
Total real estate properties	52,726
Accumulated Depreciation	$ 813
Behavioral facilities [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,300
Buildings, Improvements, and Lease Intangibles	18,803
Total real estate properties	20,103
Accumulated Depreciation	$ 627
Behavioral facilities [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 270
Buildings, Improvements, and Lease Intangibles	2,651
Total real estate properties	2,921
Accumulated Depreciation	$ 127
Behavioral facilities [Member] | Ohio [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 514
Buildings, Improvements, and Lease Intangibles	4,153
Total real estate properties	4,667
Accumulated Depreciation	$ 52
Behavioral facilities [Member] | West Virginia [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,138
Buildings, Improvements, and Lease Intangibles	22,897
Total real estate properties	25,035
Accumulated Depreciation	$ 7
Corporate property [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	0
Land and Land Improvements	$ 0
Buildings, Improvements, and Lease Intangibles	2,011
Personal Property	112
Total real estate properties	2,123
Accumulated Depreciation	$ 99
Total Properties [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	79
Land and Land Improvements	$ 39,810
Buildings, Improvements, and Lease Intangibles	307,492
Personal Property	112
Total real estate properties	347,414
Accumulated Depreciation	$ 31,153

XML

Real Estate Leases (Details) $ in Thousands	Sep. 30, 2017 USD ($)
Leases [Abstract]
2017	$ 8,292
2018	30,409
2019	27,202
2020	24,497
2021	21,541
2022 and thereafter	134,018
Total	$ 245,959

XML

Real Estate Acquisitions (Details) ft² in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2017 USD ($) ft² real_estate_property	Jun. 30, 2017 USD ($) ft² real_estate_property	Mar. 31, 2017 USD ($) ft² real_estate_property	Sep. 30, 2017 USD ($) ft²
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties acquired | real_estate_property	2	10	10
Area of real estate property (in square feet) | ft²		203	145
Aggregate purchase price	$ 28,300	$ 36,200	$ 28,500
Percentage of properties that were leased at acquisition	100.00%	100.00%	95.20%
Transaction costs	$ 65			$ 65
Business Acquisition, Mezzanine Loan Transaction Costs				11
General and Administrative Expense [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Transaction costs		$ 300	$ 400
Two Properties Acquired in Third Quarter 2017 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenue from properties acquired	44
Net income (loss) from properties acquired	$ 31
10 Properties Acquired in 2nd Quarter of 2017 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash consideration		$ 35,900
Revenue from properties acquired				1,300
Net income (loss) from properties acquired				600
10 Properties Acquired in First Quarter 2017 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash consideration			28,400
Revenue from properties acquired				1,900
Net income (loss) from properties acquired				$ 500
Corporate Property [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Area of real estate property (in square feet) | ft²	147			147
Property Adjacent To Corporate Property [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash consideration			$ 900
Unsecured Debt [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Business Combinations, Mezzanine Loan	$ 5,000			$ 5,000

XML

Real Estate Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
		Mar. 31, 2017	Sep. 30, 2017	Dec. 31, 2016
Business Acquisition [Line Items]
Land and land improvements			$ 39,810	$ 29,884
Land Improvements [Member] | Minimum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			3 years
Land Improvements [Member] | Maximum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			15 years
Building [Member] | Minimum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			20 years
Building [Member] | Maximum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			40 years
Series of Individually Immaterial Business Acquisitions [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Land and land improvements			$ 9,715
Building and building improvements			74,891
Intangibles:
Total intangibles			9,527
Accounts receivable and other assets assumed			32
Accounts payable, accrued liabilities and other liabilities assumed	[1]		(416)
Prorated rent, interest and operating expense reimbursement amounts collected			(307)
Total cash consideration			93,442
Series of Individually Immaterial Business Acquisitions [Member] | In Place Leases [Member]
Intangibles:
Lease intangibles			$ 9,527
Series of Individually Immaterial Business Acquisitions [Member] | Minimum [Member] | In Place Leases [Member]
Intangibles:
Estimated useful life (in years)			1 year 5 months
Series of Individually Immaterial Business Acquisitions [Member] | Maximum [Member] | In Place Leases [Member]
Intangibles:
Estimated useful life (in years)			8 years 11 months
Series of Individually Immaterial Business Acquisitions [Member] | Land Improvements [Member] | Minimum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			5 years
Series of Individually Immaterial Business Acquisitions [Member] | Land Improvements [Member] | Maximum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			7 years 6 months
Series of Individually Immaterial Business Acquisitions [Member] | Building [Member] | Minimum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			20 years
Series of Individually Immaterial Business Acquisitions [Member] | Building [Member] | Maximum [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Estimated useful life (in years)			40 years
10 Properties Acquired in First Quarter 2017 [Member]
Business Acquisition [Line Items]
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual			$ 1,900
Intangibles:
Total cash consideration		$ 28,400

[1] Includes security deposits received.

XML

Debt, net - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Debt, net	$ 59,284	$ 51,000
Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	60,000
Revolving Credit Facility [Member] | Line of Credit [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	0	51,000
5 Year Term Loan [Member] | Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	29,648	0
7 Year Term Loan [Member] | Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	$ 29,636	$ 0

XML

Debt, net (Details)		9 Months Ended
	Mar. 29, 2017 USD ($) option	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Line of Credit Facility [Line Items]
Draw on term loan borrowings		$ 60,000,000	$ 0
Amount outstanding		$ 59,284,000		$ 51,000,000
Second Amended And Restated Credit Facility [Member]
Line of Credit Facility [Line Items]
Minimum draw on debt instrument	$ 10,000,000
Fees and other costs	784,000
Maximum percentage of total book capitalization		40.00%
Second Amended And Restated Credit Facility [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount	$ 100,000,000
Unused borrowing commitment fee percentage	0.35%
Amount outstanding		$ 60,000,000
Weighted average interest rate percentage		4.34%
Remaining borrowing capacity		$ 40,000,000
Second Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	2.20%
Second Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	2.90%
Second Amended And Restated Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Second Amended And Restated Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.90%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000
Number of options to extend | option	2
Amount outstanding		0		51,000,000
Remaining borrowing capacity		150,000,000
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.75%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	2.75%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	0.75%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage	1.75%
Second Amended And Restated Credit Facility [Member] | Credit Facility, Accordion Feature [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 450,000,000
Second Amended And Restated Credit Facility [Member] | 5 Year Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	5 years
Draw on term loan borrowings	$ 30,000,000
Amount outstanding		29,648,000		0
Second Amended And Restated Credit Facility [Member] | 7 Year Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	7 years
Draw on term loan borrowings		30,000,000
Amount outstanding		$ 29,636,000		$ 0
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 1 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.25%
Percentage of borrowing capacity outstanding	33.30%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 2 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.35%
Percentage of borrowing capacity outstanding	33.30%

XML

Derivative Financial Instruments (Details)	9 Months Ended
	Sep. 30, 2017 USD ($) derivative_instrument
Derivative [Line Items]
Cash flow hedges reclassified to interest expense	$ 348,000
Cash Flow Hedging [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Number outstanding interest rate derivatives | derivative_instrument	2
Notional amount	$ 60,000,000
Fair value of derivatives in net liability position	389,000
Aggregate termination value	411,000
Other Liabilities [Member] | Cash Flow Hedging [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Fair value of derivate liabilities	$ 386,000

XML

Derivative Financial Instruments - Cash Flow Hedging (Details) - Interest Rate Contract [Member] - Cash Flow Hedging [Member] - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI on derivative	$ (74)	$ (672)
Amount of gain (loss) reclassified from accumulated OCI into interest expense	(124)	(286)
Amount of gain (loss) recognized in income on derivative (ineffective portion, reclassifications of missed forecasted transactions and amounts excluded from effectiveness testing)	$ 1,091	$ 2,897

XML

Stockholders' Equity - Reconciliation of Common Stock (Details) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	12,988,482	7,596,940
Issuance of common stock (in shares)	4,887,500	5,175,000
Restricted stock-based awards (in shares)	209,816	216,542
Balance, end of period (in shares)	18,085,798	12,988,482
Common Stock, Shares, Outstanding	18,085,798	12,988,482

XML

Stockholders' Equity - Equity Offering (Details) - USD ($)		1 Months Ended
	Jul. 26, 2017	Jul. 31, 2017	Sep. 13, 2016
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of stock		$ 114,600,000
Remaining availability under shelf registration		$ 635,400,000
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Shelf registration amount			$ 750,000,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of stock	$ 108,900,000
Public Offering [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of Stock, Number of Shares Issued in Transaction	4,887,500
Over-Allotment Option [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of Stock, Number of Shares Issued in Transaction	637,500
Revolving Credit Facility [Member] | Line of Credit [Member]
Subsidiary, Sale of Stock [Line Items]
Extinguishment of Debt, Amount	$ 58,000,000

XML

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Earnings Per Share [Abstract]
Net income	$ 579	$ 1,064	$ 1,958	$ 1,688
Participating securities' share in earnings	(200)	0	(526)	0
Net income, less participating securities' share in earnings	$ 379	$ 1,064	$ 1,432	$ 1,688
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding (in shares)	16,719,150	12,948,097	14,319,231	10,972,011
Unvested restricted stock (in shares)	(477,164)	(261,914)	(434,755)	(219,678)
Weighted average Common Shares outstanding–Basic (in shares)	16,241,986	12,686,183	13,884,476	10,752,333
Weighted average Common Shares outstanding–Basic (in shares)	16,241,986	12,686,183	13,884,476	10,752,333
Dilutive effect of restricted stock (in shares)	0	64,784	0	49,762
Weighted average Common Shares outstanding –Diluted (in shares)	16,241,986	12,750,967	13,884,476	10,802,095
Basic Net Income per Common Share (in dollars per share)	$ 0.02	$ 0.08	$ 0.10	$ 0.16
Diluted Net Income per Common Share (in dollars per share)	$ 0.02	$ 0.08	$ 0.10	$ 0.16

XML

Incentive Plan (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
2014 Incentive Plan [Member] | Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 0.4	$ 0.2	$ 1.1	$ 0.5

XML

Incentive Plan - Restricted Stock Activity (Details) - 2014 Incentive Plan [Member] - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Stock-based awards, beginning of period (in shares)	434,980	224,895	302,299	85,757
Granted (in shares)	77,135	77,404	209,816	216,542
Stock-based awards, end of period (in shares)	512,115	302,299	512,115	302,299
Restricted Common Stock, Stock in Lieu of Compensation [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	16,452	38,703	80,580	104,110
Restricted Common Stock, Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	60,683	38,701	129,236	112,432

XML

Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Notes receivable	$ 5,704	$ 0
Accounts receivable	1,918	2,472
Deferred Rent Receivables, Net	1,723	744
Allowance for doubtful accounts	(293)	(154)
Prepaid assets	355	260
Deferred financing costs, net	716	1,010
Above-market intangible assets, net	0	25
Other	653	486
Other assets, net	$ 10,776	$ 4,843

XML

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable, net	$ 10,633	$ 10,786
Notes receivable	5,704	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable, fair value	10,633	10,786
Notes receivable, fair value	$ 5,669	$ 0

XML

Subsequent Events (Details) $ / shares in Units, $ in Millions		1 Months Ended	3 Months Ended				9 Months Ended
	Nov. 02, 2017 $ / shares	Nov. 07, 2017 USD ($) ft² real_estate_property	Sep. 30, 2017 USD ($) real_estate_property $ / shares	Jun. 30, 2017 USD ($) ft² real_estate_property	Mar. 31, 2017 USD ($) ft² real_estate_property	Sep. 30, 2016 $ / shares	Sep. 30, 2017 $ / shares	Sep. 30, 2016 $ / shares
Subsequent Event [Line Items]
Dividend declared (in dollars per share) | $ / shares			$ 0.3925			$ 0.3825	$ 1.17	$ 1.14
Number of Real Estate Properties Acquired | real_estate_property			2	10	10
Area of Real Estate Property | ft²				203,000	145,000
Business Combination, Consideration Transferred | $			$ 28.3	$ 36.2	$ 28.5
Percentage of Acquired Building Leased at Acquisition			100.00%	100.00%	95.20%
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividend declared (in dollars per share) | $ / shares	$ 0.395
Number of Real Estate Properties Acquired | real_estate_property		3
Scenario, Forecast [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Area of Real Estate Property | ft²		105,500
Business Combination, Consideration Transferred | $		$ 25.9
Percentage of Acquired Building Leased at Acquisition		100.00%